Цинк и рак предстательной железы

Фигуровский Н.А. Очерк общей истории химии. От древнейших времен до начала XIX в. Москва: Наука, 1969. Т. 1. 455 с.

Вернадский В.И. Живое вещество. Москва: Наука, 1978. 361 с.

Vernadsky V.I. Scientific thought as a planetary phenomenon. Moscow: Nongovernmental Ecological Vernadsky V.I. Foundation, 1997. 265 p.

Виноградов А.П. Труды Биогеохимической лаборатории АН СССР. 1935. N 3.

Войнар А.И. Биологическая роль микроэлементов в организме животных и человека. Москва: Высшая школа, 1960. 544 с.

Ковальский В.В. Геохимическая экология. Очерки. Москва: Наука, 1974. 299 с.

Zaichick V. Medical elementology as a new scientific discipline // J. Radioanal. Nucl. Chem. 2006. Vol. 269, N 2. P. 303–309. doi: 10.1007/s10967-006-0383-3 EDN: LJNWDV

Зайчик В., Агаджанян Н.А. Некоторые методологические вопросы медицинской элементологии // Вестник восстановительной медицины. 2004. № 3(9). P. 19–23. EDN: SFQQSB

Zaichick V., Ermidou-Pollet S., Pollet S. Bio- and medical elementology as a new scientific discipline. 1. Fundamental postulates In: Proceedings of 5th international symposium on trace elements in human: New Perspectives (13–15 October 2005, Athens, Greece). Athens, Greece: Athens University, 2005. P. 24–30.

Zaichick V., Ermidou-Pollet S., Pollet S. Medical elementology: a new scientific discipline // Trace Elements and Electrolytes. 2007. Vol. 24, N 2. P. 69–74. doi: 10.5414/tep24069 EDN: LKGIGX

Авцин А.П., Жаворонков А.А., Риш М.А., и др. Микроэлементозы человека. Москва: Медицина, 1991. 495 c.

Chellan P., Sadler P.J. The elements of life and medicines // Philos. Trans. A Math. Phys. Eng. Sci. 2015. Vol. 373, N 2037. P. 20140182. doi: 10.1098/rsta.2014.0182 EDN: USZVAF

McNeal J.E. Normal anatomy of the prostate and changes in benign prostatic hypertrophy and carcinoma // Semin. Ultrasound CT MR. 1988. Vol. 9, N 5. P. 329–334.

McNeal J.E. Anatomy and embryology // The Prostate / Eds. Fitzpatrick J.M., Krane R.J. Edinburgh: Churchill Livingstone, 1989. P. 3–9.

Benninghoff A. Makroskopische Anatomie, Embryologie und Histologie des Menschen. 15. Auflage. München; Wien; Baltimore: Urban und Schwarzenberg, 1993.

Cohen R.J., McNeal J.E., Redmond S.L., et al. Luminal contents of benign and malignant prostatic glands: correspondence to altered secretory mechanisms // Hum. Pathol. 2000. Vol. 31, N 1. P. 94–100. doi: 10.1016/S0046-8177(00)80204-X

Deering R.E., Choongkittaworn M., Bigler S.A., et al. Morphometric quantitation of stroma in human benign prostatic hyperplasia // Urology. 1994. Vol. 44, N 1. P. 64–70. doi: 10.1016/S0090-4295(94)80011-1

Авцын А.П., Дунчик В.Н., Жаворонков А.А., и др. Гистологическое строение предстательной железы и содержание в ней цинка в различные возрастные периоды // Архив анатомии, гистологии и эмбриологии. 1981. Vol. 81, N 11. P. 76–83.

Andrews G.S. The histology of the human fetal and prepubertal prostates // J. Anat. 1951. Vol. 85. P. 44–54.

Weibel E.R., Gomez D.M. A principle for counting tissue structures on random sections // J. Appl. Physiol. 1962. Vol. 17. P. 343–348. doi: 10.1152/jappl.1962.17.2.343

Bartsch G., Muller H.R., Oberholzer M., et al. Light microscopic stereological analysis of the normal human prostate and of benign prostatic hyperplasia // J. Urol. 1979. Vol. 122, N 4. P. 487–491. doi: 10.1016/S0022-5347(17)56476-9

Shapiro E., Hartanto V., Perlman E.J., et al. Morphometric analysis of paediatric and nonhyperplastic prostate glands: Evidence that BPH is not a unique stromal process // Prostate. 1997. Vol. 33, N 3. P. 177–182. doi: 10.1002/(SICI)1097-0045(19971101)33:3<177::AID-PROS5>3.0.CO;2-G

Rohr H.P., Bartsch G. Human benign prostatic hyperplasia: a stromal disease. New perspectives by quantitative morphology // Urology. 1980. Vol. 16, N 6. P. 625–633. doi: 10.1016/0090-4295(80)90577-4

Arenas M.I., Romo E., Royuela M., et al. Morphometric evaluation of the human prostate // Int. J. Androl. 2001. Vol. 24, N 1. P. 37–47. doi: 10.1046/j.1365-2605.2001.00267.x

Chagas M.A., Babinski M.A., Costa W.S., et al. Stromal and acinar components of the transition zone in normal and hyperplastic human prostate // BJU Int. 2002. Vol. 89, N 7. P. 699–702. doi: 10.1046/j.1464-410X.2002.02724.x EDN: BACHBX

Matsuda T., Fujime M., Suda K. Relationship between the prostatic tissue components and natural history of benign prostatic hyperplasia // Anal. Quant. Cytol. Histol. 2006. Vol. 28, N 3. P. 121–124.

Zaichick S., Zaichick V. Relations of morphometric parameters to zinc content in paediatric and nonhyperplastic young adult prostate glands // Andrology. 2013. Vol. 1, N 1. P. 139–146. doi: 10.1111/j.2047-2927.2012.00005.x EDN: SDHMYF

Автандилов Г.Г. Морфометрия и патология. Москва: Медицина, 1973. 248 c.

Zaichick V., Zaichick S. Age-related histological and zinc content changes in adult nonhyperplastic prostate glands // Age. 2014. Vol. 36, N 1. P. 167–181. doi: 10.1007/s11357-013-9561-8 EDN: UFPWVL

McNeal J.E. Origin and evolution of benign prostatic enlargement // Invest. Urol. 1978. Vol. 15, N 4. P. 340–345.

Cunha G.R., Hayward S.W., Wang Y.Z., et al. Role of the stromal microenvironment in carcinogenesis of the prostate // Int. J. Cancer. 2003. Vol. 107, N 1. P. 1–10. doi: 10.1002/ijc.11335

Lee K.L., Peehl D.M. Molecular and cellular pathogenesis of benign prostatic hyperplasia // J. Urol. 2004. Vol. 172, N 5 Pt 1. P. 1784–1791. doi: 10.1097/01.ju.0000133655.71782.14

Li W., Wu C.-L., Febbo P.G., et al. Stromally expressed c-Jun regulates proliferation of prostate epithelial cells // Am. J. Pathol. 2007. Vol. 171, N 4. P. 1189–1198. doi: 10.2353/ajpath.2007.070285

Deng F.M., Xia T.L., Gu F.L., et al. A quantitative morphometry of the normal and the benign hyperplastic prostate in Chinese // Chinese J. Urol. 1995. Vol. 12.

Pirus Y.F. The male prostate morphological changes in postnatal ontogenesis. Ph.D. dissertation. Ternopil: Ternopil State Medical University of the Ministry of Public Health of Ukraine, 2006.

Zaichick V., Zaichick S. Instrumental effect on the contamination of biomedical samples while sampling // J. Anal. Chem. 1996. Vol. 51, N 12. P. 1200–1205. EDN: LDWMAV

Aoki Y., Arai Y., Maeda H., et al. Racial differences in cellular composition of benign prostatic hyperplasia // Prostate. 2001. Vol. 49, N 4. P. 243–250. doi: 10.1002/pros.10019

Lepor H. Pathophysiology of benign prostatic hyperplasia in the aging male population // Rev. Urol. 2005. Vol. 7, Suppl 4. P. S3–S12.

Kim H.S., Lee S.W., Kim E.K., et al. Relationships between relative proportion of tissue components, urodynamic parameters, and low urinary tract symptoms in patients with benign prostatic hyperplasia // Korean. J. Urol. 2009. Vol. 50, N 9. P. 859–864. doi: 10.4111/kju.2009.50.9.859

Babinski M.A., Chagas M.A., Costa W.S., et al. Prostatic epithelial and luminal area in the transition zone acini: morphometric analysis in normal and hyperplastic human prostate // BJU Int. 2003. Vol. 92, N 6. P. 592–596. doi: 10.1046/j.1464-410X.2003.04433.x EDN: ETWTNZ

Huggins C., Scott W.W., Heinen J.H. Chemical composition of human semen and of the secretion of the prostate and seminal vesicles // Amer. J. Physiol. 1942. Vol. 136, N 3. P. 467–473. doi: 10.1152/ajplegacy.1942.136.3.467

Zaichick V. The prostatic urethra as a Venturi effect urine-jet pump to drain prostatic fluid // Med. Hypotheses. 2014. Vol. 83, N 1. P. 65–68. doi: 10.1016/j.mehy.2014.04.006 EDN: SKUZNX

Isaacs J.T. Prostatic structure and function in relation to the etiology of prostatic cancer // Prostate. 1983. Vol. 4, N 4. P. 351–366. doi: 10.1002/pros.2990040405

McNeal J.E. The prostate and prostatic urethra: a morphologic synthesis // J. Urol. 1972. Vol. 107, N 6. P. 1008–1016. doi: 10.1016/S0022-5347(17)61195-9

McNeal J.E. Normal histology of the prostate // Am. J. Surg. Pathol. 1988. Vol. 12, N 8. P. 619–633. doi: 10.1097/00000478-198808000-00003

Carola R., Harley J.P., Noback C.R. Human anatomy and physiology. New York: McGraw-Hill Publiching Company, 1990. 925 p.

Papka R.E. Anatomy. New York: Springer, 1995. 248 p.

Винник Ю.Ю., Лебедев Е.Ю., Николаев В.Г., и др. Гистоморфометрические особенности простаты // Сб. науч. тр. IX научно-практической конференции урологов Сибири с международным участием. Красноярск, 2010. С. 265–266.

Винник Ю.Ю., Николаев В.Г., Лебедев Е.Ю. Макроанатомические особенности строения уретровезикального сегмента у молодых мужчин в зависимости от соматотипа // Biomed Biosoc Anthropol. 2007. Vol. 9. P. 234.

Фирсов М.А., Андрейчиков А.В., Зудилова С.А., et al. Анатомия уретровезикального сегмента предстательной железы у мужчин, относящихся к различным расам // Успехи современного естествознания. 2003. № 7. С. 24–28. EDN: JGVIEU

Blanker M.H. Normal values and determinants of urogenital tract (dys)function in older men: The Krimpen Study. Rotterdam: Optima Grafische Communicatie, 2002. 160 p.

Schmidt F., Shin P., Jorgensen T.M., et al. Urodynamic patterns of normal male micturition: influence of water consumption on urine production and detrusor function // J. Urol. 2002. Vol. 168, N 4 Pt 1. P. 1458–1463. doi: 10.1097/00005392-200210010-00037

Suebnukanwattana T., Lohsiriwat S., Chaikomin R., et al. Uroflowmetry in normal Thai subjects // J. Med. Assoc. Thai. 2003. Vol. 86, N 4. P. 353–360.

Kumar V., Dhabalia J.V., Nelivigi G.G., et al. Age, gender, and voided volume dependency of peak urinary flow rate and uroflowmetry nomogram in the Indian population // Indian. J. Urol. 2009. Vol. 25, N 4. P. 461–466. doi: 10.4103/0970-1591.57912

Cindolo L., De Nunzio C., Sountoulides P., et al. The influence of ejaculation and abstinence on urinary flow rates // Neurourol. Urodyn. 2011. Vol. 30, N 8. P. 1571–1575. doi: 10.1002/nau.21157

Fang Q., Song B., Li W., et al. Role of UPP in evaluating bladder outlet obstruction due to benign prostatic enlargement // Neurourol. Urodyn. 2007. Vol. 26, N 6. P. 842–846. doi: 10.1002/nau.20227

Jung A., Schill W.B. Male sexuality with advancing age // Eur. J. Obstet. Gynecol. Reprod. Biol. 2004. Vol. 113, N 2. P. 123–125. doi: 10.1016/j.ejogrb.2003.10.007

Bertrand G., Vladesco R. Intervention probable du zinc dans les phenomenes de fecundation chez les animaux vertebres // Compt. Rend. Acad. Sci. (Paris). 1921. Vol. 173. P. 176–180.

Mawson C.A., Fischer M.J. The occurrence of zinc in the human prostate gland // Can. J. Med. Sci. 1952. Vol. 30, N 4. P. 336–339. doi: 10.1139/cjms52-043

Zaichick V., Sviridova T., Zaichick S. Zinc in human prostate gland: normal, hyperplastic and cancerous // Int. Urol. Nephrol. 1997. Vol. 29, N 5. P. 565–574. doi: 10.1007/BF02552202 EDN: LDZAPP

Zaichick V. Sampling, sample storage and preparation of biomaterials for INAA in clinical medicine, occupational and environmental health // Harmonization of health-related environmental measurements using nuclear and isotopic techniques. Vienna: IAEA, 1997. P. 123–133.

Zaichick V. Losses of chemical elements in biological samples under the dry ashing process // Trace Elements in Medicine. 2004. Т. 5, № 3. P. 17–22.

Зайчик В.Е., Зайчик С.В. Влияние инструментария на загрязнение медико-биологических образцов в процессе пробоотбора // ЖАХ. 1996. Т. 51, № 12. С. 1322–1327.

Zaichick V. Application of synthetic reference materials in the Medical Radiological Research Centre // Fresenius. J. Anal. Chem. 1995. Vol. 352, N 1–2. P. 219–223. doi: 10.1007/BF00322330 EDN: XOXWYY

Zaichick V., Zaichick S. A search for losses of chemical elements during freeze-drying of biological materials // J. Radioanal. Nucl. Chem. 1997. Vol. 218, N 2. P. 249–253. doi: 10.1007/BF02039345 EDN: LEBXCX

Корело А.М., Зайчик В.Е. Компьютерная программа расчета оптимальных режимов многоэлементного нейтронно-активационного анализа медицинских и биологических объектов // Активационный анализ в охране окружающей среды. Дубна: ОИЯИ, 1993. P. 326–332.

Parr R. Inter-comparison of minor and trace elements in IAEA animal muscle (H-4). Vienna: IAEA, Report No 2, 1980. ANNUAL REPORT - 1980 - INIS-IAEA.

M’Baku S.B., Parr R.M. Interlaboratory study of trace and other elements in the IAEA powdered human hair reference material, HH-1 // J. Radioanal. Chem. 1982. Vol. 69. P. 171–180. doi: 10.1007/BF02515922

Плотников Р.И., Пшеничный Г.А. Флюоресцентный рентгенорадиометрический анализ. Москва: Атомиздат, 1973. 264 c.

Леонов А.И., Зайчик В.Е. Выбор оптимальных геометрических параметров в системе «источник-проба-детектор» при рентгенофлуоресцентном анализе с использованием Si(Li)-детектора и 109Cd // Вопросы атом. науки и техники, Серия: Общая и ядерная физика (Харьков). 1979. Т. 2, № 8. С. 70–73.

ICRP (International Commission on Radiological Protection). Report of the task group on Reference man. ICRP Report No 23. Oxford: Pergamon Press, 1975. 480 p.

Iyengar G.V., Kollmer W.E., Bowen H.G.M. The elemental composition of human tissues and body fluids. A compilation of values for adults. Weinheim: Verlag Chemie, 1978. 151 p.

Маренков О.С., Комяк Н.И. Фотонные коэффициенты взаимодействия в рентгенорадиометрическом анализе. Ленинград: Энергоатомиздат, 1988. 221 c.

Mackenzie A.R., Hall T., Whitmore W.F. Jr. Zinc content of expressed human prostate fluid // Nature (London). 1962. Vol. 193. P. 72–73. doi: 10.1038/193072a0

Marmar J.L., Katz S., Praiss D.E., et al. Values for zinc in whole semen, fraction of split ejaculate and expressed prostatic fluid // Urology. 1980. Vol. 16, N 5. P. 478–480. doi: 10.1016/0090-4295(80)90599-3

Zaichick V., Sviridova T., Zaichick S. Zinc concentration in human prostatic fluid: normal, chronic prostatitis, adenoma, and cancer // Int. Urol. Nephrol. 1996. Vol. 28, N 5. P. 687–694. doi: 10.1007/BF02552165 EDN: LDWHPV

Costello L.C., Franklin R.B. Prostatic fluid electrolyte composition for the screening of prostate cancer: a potential solution to a major problem // Prostate Cancer Prostate Dis. 2009. Vol. 12, N 1. P. 17–24. doi: 10.1038/pcan.2008.19 EDN: LONIBH

Moore R.A., Miller M.L., McLellan A. The chemical composition of prostatic secretion in relation to benign hypertrophy of the prostate // J. Urol. 1941. Vol. 46, N 1. P. 132–137. doi: 10.1016/S0022-5347(17)70902-0

Homonnai Z.T., Matzkin H., Fainman N., et al. The cation composition of the seminal plasma and prostatic fluid and its correlation to semen quality // Fertil Steril. 1978. Vol. 29, N 5. P. 539–542. doi: 10.1016/S0015-0282(16)43281-4

Kavanagh J.P., Darby C. The interrelationships between acid phosphatase, aminopeptidase, diamine oxidase, citric acid, β-glucuronidase, pH and zinc in human prostate fluid // Int. J. Androl. 1982. Vol. 5, N 5. P. 503–512. doi:10.1111/j.1365-2605.1982.tb00282.x

Kavanagh J.P. Sodium, potassium, calcium, magnesium, zinc, citrate and chloride content of human prostatic and seminal fluid // J. Reprod. Fertil. 1985. Vol. 75, N 1. P. 35–41. doi: 10.1530/jrf.0.0750035

Romics I., Bach D. Zn, Ca and Na levels in the prostatic secretion of patients with prostatic adenoma // Int Urol Nephrol. 1991. Vol. 23, N 1. P. 45–49. doi: 10.1007/BF02549727

Burgos M.H. Biochemical and functional properties related to sperm metabolism and fertility // Male accessory sex organs / Ed. Brandes D. New York: Academic press, 1974. P. 151–160. doi: 10.1016/B978-0-12-125650-0.50010-7

Gómez Y., Arocha F., Espinoza F., et al. Niveles de zinc en líquido prostático de pacientes con patologías de próstata // Invest. Clin. 2007. Vol. 48, N 3. P. 287–294. EDN: LOZWRZ

Mo Z.-N., Huang W.-H., Chen J., et al. Early and late long-term effects of vasectomy on Zn, Cd, and Cu levels in prostatic fluid and serum // Asian J. Androl. 2000. Vol. 2, N 2. P. 121–124.

Coleman J.E. Zinc proteins: enzymes, storage proteins, transcription factors, and replication proteins // Annu. Rev. Biochem. 1992. Vol. 61. P. 897–946. doi: 10.1146/annurev.bi.61.070192.004341

Costello L.C., Franklin R.B. Novel role of zinc in the regulation of prostate citrate metabolism and its implications in prostate cancer // Prostate. 1998. Vol. 35, N. P. 285–296. doi: 10.1002/(SICI)1097-0045(19980601)35:4<285::AID-PROS8>3.0.CO;2-F

Beck F.W., Prasad A.S., Butler C.E., et al. Differential expression of hZnT-4 in human prostate tissues // Prostate. 2004. Vol. 58, N 4. P. 374–381. doi: 10.1002/pros.10344 EDN: LOZVSZ

Franklin R.B., Feng P., Milon B., et al. hZIPI zinc uptake transporter down regulation and zinc depletion in prostate cancer // Mol. Cancer. 2005. Vol. 4. P. 32. doi: 10.1186/1476-4598-4-32

Desouki M.M., Geradts J., Milon B., et al. hZip2 and hZip3 zinc transporters are down regulated in human prostate adenocarcinomatous glands // Mol. Cancer. 2007. Vol. 6. P. 37. doi: 10.1186/1476-4598-6-37 EDN: YYMLTT

Ide-Ektessabi A., Fujisawa F., Sugiruma K., et al. Quantitative analysis of zinc in prostate cancer tissue using synchrotron radiation microbeams // X-Ray Spectrom. 2002. Vol. 31, N 1. P. 7–11. doi: 10.1002/xrs.532

Hoare R., Delory G.E., Penner D.W. Zinc and acid phosphatase in the human prostate // Cancer. 1956. Vol. 9, N 4. P. 721–726. doi: 10.1002/1097-0142(195607/08)9:4<721::AID-CNCR2820090415>3.0.CO;2-Y

Siegal E., Graig F.A., Drystall M.M., et al. Distribution of 65Zn in the prostate and other organs of man // Br. J. Cancer. 1961. Vol. 15, N 3. P. 647–664. doi: 10.1038/bjc.1961.74

Kar A.B., Chowdhury A.R. Distribution of zinc in the subcellular fractions of human prostate // Curr. Sci. 1968. Vol. 37. P. 375–376.

Dhar N.K., Goel T.C., Dube P.C., et al. Distribution and concentration of zinc in the subcellular fractions of benign hyperplastic and malignant neoplastic human prostate // Exp. Mol. Pathol. 1973. Vol. 19. P. 139–142. doi: 10.1016/0014-4800(73)90073-7

Morita H. Histochemical study of human prostate. II. Ultrastructural and XMA observation of zinc in the hyperplastic and neoplastic prostate // Jpn. J. Urol. 1981. Vol. 72, N 6. P. 717–729. doi: 10.5980/jpnjurol1928.72.6_717

Leake A., Chisholm G.D., Habib F.K. The distribution of zinc in human prostate // Prostate. 1983. Vol. 4. P. 421–422.

Tvedt K.E., Halgunset J., Kopstad G., et al. Intracellular distribution of calcium and zinc in normal, hyperplastic, and neoplastic human prostate: X-ray microanalysis of freeze-dried cryosections // Prostate. 1989. Vol. 15. P. 41–51. doi: 10.1002/pros.2990150105

Bataineh Z.M., Bani Hani I.H., Al-Alami J.R. Zinc in normal and pathological human prostate gland // Saudi Med J. 2002. Vol. 23, N 2. P. 218–220. EDN: LOZVGH

Zaichick S., Zaichick V. Method and portable facility for energy-dispersive X-ray fluorescent analysis of zinc content in needle-biopsy specimens of prostate // X-Ray Spectrom. 2010. Vol. 39. P. 83–89. doi: 10.1002/xrs.1233 EDN: MXLNAZ

Zaichick S., Zaichick V. The Br, Fe, Rb, Sr, and Zn content and interrelation in intact and morphologic normal prostate tissue of adult men investigated by energy dispersive X-ray fluorescent analysis // X-Ray Spectrom. 2011. Vol. 40, N 6. P. 464–469. doi: 10.1002/xrs.1370 EDN: PEDRTV

Hienzsch E., Schneider H.J., Anke M. Vergleichende Untersuchungen zum Mengen- und Spurenelementgehalt der normalen Prostata, des Prostataadenoms und des Prostatakarzinoms // Zeitschrift für Urologie und Nephrologie. 1970. Vol. 63, N 7. P. 543–546.

Leissner K.M., Fielkegard B., Tisell L.E. Concentration and content of zinc in human prostate // Invest. Urol. 1980. Vol. 18, N 1. P. 32–35.

Feustel A., Wennrich R., Steiniger D., Klauss P. Zinc and cadmium concentration in prostatic carcinoma of different histological grading in comparison to normal prostate tissue and adenofibromyomatosis (BPH) // Urol. Res. 1982. Vol. 10. P. 301–303. doi: 10.1007/BF00255877

Tisell L.-E., Fjelkegard B., Leissner K.H. Zinc concentration and content of the dorsal, lateral and medial prostatic lobes and of periurethral adenomas in man // J. Urol. 1982. Vol. 128, N 2. P. 403–405. doi: 10.1016/S0022-5347(17)52946-8

Picurelli L., Olcina P.V., Roig M.D., Ferrer J. Determination of Fe, Mg, Cu, and Zn in normal and pathological prostatic tissue // Actas. Urol. Esp. 1991. Vol. 15, N 4. P. 344–350.

Oldereid N.B., Thomassen Y., Attramadal A., et al. Concentrations of lead, cadmium and zinc in the tissues of reproductive organs of men // J. Reprod. Fertil. 1993. Vol. 99, N 2. P. 421–425. doi: 10.1530/jrf.0.0990421

Györkey F. Some aspects of cancer of the prostate gland // Methods in Cancer Research / Ed. Busch H. New York: Academic Press, 1973. Vol. 10. P. 279–386.

Guntupalli J.N., Padala S., Gummuluri A.V., et al. Trace elemental analysis of normal, benign, hypertrophic and cancerous tissues of the prostate gland using the particle-induced X-ray emission technique // Eur. J. Cancer. Prev. 2007. Vol. 16, N 2. P. 108–115. doi: 10.1097/01.cej.0000228409.75976.b6 EDN: LOZWPH

Sapota A., Daragó A., Taczalski J., Kilanowicz A. Disturbed homeostasis of zinc and other essential elements in the prostate gland dependent on the character of pathological lesions // Biometals. 2009. Vol. 22, N 6. P. 1041–1049. doi: 10.1007/s10534-009-9255-y EDN: BVLOLC

Woodard H.Q., White D.R. The composition of body tissues // Br. J. Radiol. 1986. Vol. 59, N 708. P. 1209–1218. doi: 10.1259/0007-1285-59-708-1209

Iyengar G.V. Reevaluation of the trace element content in reference men // Radiat. Phys. Chem. 1998. Vol. 51, N 4–6. P. 545–560. doi: 10.1016/S0969-806X(97)00202-8 EDN: YCIJFQ

Bozym R.A., Chimienti F., Giblin L.J., et al. Free zinc ions outside a narrow concentration range are toxic to a variety of cells in vitro // Exp. Biol. Med. (Maywood). 2010. Vol. 235, N 6. P. 741–750. doi: 10.1258/ebm.2010.009258 EDN: OAAQTF

Nemoto K., Kondo Y., Himeno S., et al. Modulation of telomerase activity by zinc in human prostatic and renal cancer cells // Biochem. Pharmacol. 2000. Vol. 59, N 4. P. 401–405. doi: 10.1016/S0006-2952(99)00334-2 EDN: AEIOHB

Sommerfeld H.J., Meeker A.K., Piatyszek M.A., et al. Telomerase activity: a prevalent marker of malignant human prostate tissue // Cancer Res. 1996. Vol. 56, N 1. P. 218–226.

Chandra R.K. Excessive intake of zinc impairs immune responses // JAMA. 1984. Vol. 252, N 11. P. 1443–1446. doi: 10.1001/jama.1984.03350110043027

Samman S., Roberts D.C. The effect of zinc supplements on lipoproteins and copper status // Atherosclerosis. 1988. Vol. 70, N 3. P. 247–252. doi: 10.1016/0021-9150(88)90175-X

Nickel J.C. Inflammation and benign prostatic hyperplasia // Urol. Clin. North. Am. 2008. Vol. 35, N 1. P. 109–115. doi: 10.1016/j.ucl.2007.09.012

Robert G., Descazeaud A., Nicolaïew N., et al. Inflammation in benign prostatic hyperplasia: a 282 patients’ immunohistochemical analysis // Prostate. 2009. Vol. 69, N 16. P. 1774–1780. doi: 10.1002/pros.21027

Holmes M.D., Pollak M.N., Willett W.C., Hankinson S.E. Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations // Cancer. Epidemiol. Biomarkers Prev. 2002. Vol. 11, N 9. P. 852–861.

Prasad A.S., Mantzoros C.S., Beck F.W., Hess J.W., Brewer G.J. Zinc status and serum testosterone levels of healthy adults // Nutrition. 1996. Vol. 12, N 5. P. 344–348. doi: 10.1016/S0899-9007(96)80058-X

Leake A., Chrisholm G.D., Busuttil A., Habib F.K. Subcellular distribution of zinc in the benign and malignant human prostate: evidence for a direct zinc androgen interaction // Acta. Endocrinol. (Copenh). 1984. Vol. 105, N 2. P. 281–288. doi: 10.1530/acta.0.1050281

Schwartz M.K. Role of trace elements in cancer // Cancer Res. 1975. Vol. 35, N 11 Pt. 2. P. 3481–3487.

Matusik R.J., Kreis C., McNicol P., et al. Regulation of prostatic genes: role of androgens and zinc in gene expression // Biochem. Cell. Biol. 1986. Vol. 64, N 6. P. 601–607. doi: 10.1139/o86-083

Blok L.J., Grossmann M.E., Perry J.E., Tindall D.J. Characterization of an early growth response gene, which encodes a zinc finger transcription factor, potentially involved in cell cycle regulation // Mol. Endocrinol. 1995. Vol. 9, N 11. P. 1610–1620.

Зезеров Е.Г. Гормональные и молекулярно-биологические факторы патогенеза рака предстательной железы // Вопросы онкологии. 2001. Т. 47, № 2. С. 174–181. EDN: SKCFYZ

Truong-Tran A.Q., Ho L.H., Chai F., Zalewski P.D. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death // J. Nutr. 2000. Vol. 130, Suppl 5. P. 1459S–1466S. doi: 10.1093/jn/130.5.1459S EDN: YEBWQF

Kontargiris E., Vadalouka A., Ragos V., Kalfakakou V. Zinc inhibits apoptosis and maintains NEP downregulation, induced by Ropivacaine, in HaCaT cells // Biol. Trace. Elem. Res. 2012. Vol. 150, N 1–3. P. 460–466. doi: 10.1007/s12011-012-9492-8

Liang D., Yang M., Guo B., et al. Zinc inhibits H2O2-induced MC3T3-E1 cells apoptosis via MAPK and PI3K/AKT pathways // Biol. Trace. Elem. Res. 2012. Vol. 148, N 3. P. 420–429. doi: 10.1007/s12011-012-9387-8 EDN: EMTYUM

Zhang X., Liang D., Guo B., et al. Zinc inhibits high glucose-induced apoptosis in peritoneal mesothelial cells // Biol. Trace. Elem. Res. 2012. Vol. 150, N 1–3. P. 424–432. doi: 10.1007/s12011-012-9473-y EDN: BUEWBO

Banas A., Banas K., Kwiatek W.M., et al. Neoplastic disorders of prostate glands in the light of synchrotron radiation and multivariate statistical analysis // J. Biol. Inorg. Chem. 2011. Vol. 16, N 8. P. 1187–1196. doi: 10.1007/s00775-011-0807-6 EDN: PMXCCP

Costello L.C., Franklin R.B. Zinc is decreased in prostate cancer: an established relationship of prostate cancer! // J. Biol. Inorg. Chem. 2011. Vol. 16, N 1. P. 3–8. doi: 10.1007/s00775-010-0736-9 EDN: OKQNLF

Zaichick V. INAA and EDXRF applications in the age dynamics assessment of Zn content and distribution in the normal human prostate // J. Radioanal. Nucl. Chem. 2004. Vol. 262, N 1. P. 229–234. doi: 10.1023/B:JRNC.0000040879.45030.4f EDN: LIHAYT

Zaichick V., Zaichick S. INAA application in the assessment of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn mass fraction in pediatric and young adult prostate glands // J. Radioanal. Nucl. Chem. 2013. Vol. 298, N 3. P. 1559–1566. doi: 10.1007/s10967-013-2554-3 EDN: SLGKSL

Zaichick V., Zaichick S. NAA-SLR and ICP-AES Application in the assessment of mass fraction of 19 chemical elements in pediatric and young adult prostate glands // Biol. Trace Elem. Res. 2013. Vol. 156, N 1. P. 357–366. doi: 10.1007/s12011-013-9826-1 EDN: UZURAH

Zaichick V., Zaichick S. Use of neutron activation analysis and inductively coupled plasma mass spectrometry for the determination of trace elements in pediatric and young adult prostate // Am. J. Anal. Chem. 2013. Vol. 4, N 12. P. 696–706. doi: 10.4236/ajac.2013.412084

Zaichick S., Zaichick V. The effect of age on Ag, Co, Cr, Fe, Hg, Sb, Sc, Se, and Zn contents in intact human prostate investigated by neutron activation analysis // Appl. Radiat. Isot. 2011. Vol. 69, N 6. P. 827–833. doi: 10.1016/j.apradiso.2011.02.010 EDN: OHVMDR

Zaichick V., Nosenko S., Moskvina I. The effect of age on 12 chemical element contents in intact prostate of adult men investigated by inductively coupled plasma atomic emission spectrometry // Biol. Trace Elem. Res. 2012. Vol. 147, N 1–3. P. 49–58. doi: 10.1007/s12011-011-9294-4 EDN: PDPYNJ

Zaichick S., Zaichick V., Nosenko S., Moskvina I. Mass fractions of 52 trace elements and zinc trace element content ratios in intact human prostates investigated by inductively coupled plasma mass spectrometry // Biol. Trace Elem. Res. 2012. Vol. 49, N 2. P. 171–183. doi: 10.1007/s12011-012-9427-4 EDN: SOHXTD

Zaichick V., Zaichick S. INAA application in the assessment of chemical element mass fractions in adult and geriatric prostate glands // Appl. Radiat. Isot. 2014. Vol. 90. P. 62–73. doi: 10.1016/j.apradiso.2014.03.010 EDN: SKPDKX

Zaichick V., Zaichick S. Determination of trace elements in adults and geriatric prostate combining neutron activation with inductively coupled plasma atomic emission spectrometry // Open J. Biochem. 2014. Vol. 1, N 2. P. 16–33.

Zaichick V., Zaichick S. Use of INAA and ICP-MS for the assessment of trace element mass fractions in adult and geriatric prostate // J. Radioanal. Nucl. Chem. 2014. Vol. 301, N 2. P. 383–397. doi: 10.1007/s10967-014-3173-3 EDN: UEJFGP

Zaichick V. The variation with age of 67 macro- and microelement contents in nonhyperplastic prostate glands of adult and elderly males investigated by nuclear analytical and related methods // Biol. Trace Elem. Res. 2015. Vol. 168, N 1. P. 44–60. doi: 10.1007/s12011-015-0342-3 EDN: WOTUIV

Fair W.R., Cordonnier J.J. The pH of prostatic fluid: A reappraisal and therapeutic implications // J. Urol. 1978. Vol. 120, N 6. P. 695–698. doi: 10.1016/S0022-5347(17)57333-4

Carter H.B., Coffey D.S. The prostate: an increasing medical problem // Prostate. 1990. Vol. 16, N 1. P. 39–48. doi: 10.1002/pros.2990160105

Garraway W.M., Collins G.N., Lee R.J. High prevalence of benign prostatic hypertrophy in the community // Lancet. 1991. Vol. 338, N 8765. P. 469–471. doi: 10.1016/0140-6736(91)90543-X EDN: BKAXRD

Burnett A.L., Wein A.J. Benign prostatic hyperplasia in primary care: what you need to know // J. Urol. 2006. Vol. 175, N 3S. P. S19–S24. doi: 10.1016/S0022-5347(05)00310-1

Shapiro E., Hartonto V., Lepor H. Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis // J. Urol. 1992. Vol. 147, N 4. P. 1167–1169. doi: 10.1016/S0022-5347(17)37508-0

Gong E.M., Gerber G.S. Saw palmetto and benign prostatic hyperplasia // Am. J. Chin. Med. 2004. Vol. 32, N 3. P. 331–338. doi: 10.1142/S0192415X04001989

Habib F.K., Hammond G.L., Lee J.R., et al. Metal-androgen interrelationships in carcinoma and hyperplasia of the human prostate // J. Endocrinol. 1976. Vol. 71, N 1. P. 133–142. doi: 10.1677/joe.0.0710133

Habib F.K. Evaluation of androgen metabolism studies in human prostate cancer- correlation with zinc levels // Prev. Med. 1980. Vol. 9, N 5. P. 650–656. doi: 10.1016/0091-7435(80)90036-5

Vaquero M.P. Magnesium and trace elements in the elderly: intake, status and recommendations // J. Nutr. Health Aging. 2002. Vol. 6, N 2. P. 147–153.

Mocchegiani E., Muaaioli M., Giacconi R. Zinc, metallothioneins, immune responses, survival and ageing // Biogeront. 2000. Vol. 1, N 2. P. 133–143. doi: 10.1023/A:1010095930854 EDN: AGFDKZ

Ekmekcioglu C. The role of trace elements for the health of elderly individuals // Nahrung. 2001. Vol. 45, N 5. P. 309–316. doi: 10.1002/1521-3803 (20011001)45:5<309::AID-FOOD309>3.0.CO;2-0

Galván-Bobadilla A.I., García-Escamilla R.M., Gutiérrez-García N., et al. Cadmium and zinc concentrations in prostate cancer and benign prostate hyperplasia // Rev. Latinoamer. Patol. Clin. 2005. Vol. 52. P. 109–117.

Jafa A., Mahendra N.M., Chowdhury A.R., Kamboj V.P. Trace elements in prostatic tissue and plasma in prostatic diseases of man // Indian J. Cancer. 1980. Vol. 17, N 1. P. 34–37.

Kiziler A.R., Aydemir B., Guzel S., et al. May the level and ratio changes of trace elements be utilized in identification of disease progression and grade in prostatic cancer? // Trace Elem. Electrolytes. 2010. Vol. 27, N 2. P. 65–72. doi: 10.5414/TEP27065

Györkey F., Min K.-W., Huff J.A., Györkey P. Zinc and magnesium in human prostate gland: Normal, hyperplastic, and neoplastic // Cancer Res. 1967. Vol. 27, N 8. P. 1349–1353.

Zaichick S., Zaichick V. Prostatic tissue level of some androgen dependent and independent trace elements in patients with benign prostatic hyperplasia // Androl. Gynecol. Curr. Res. 2015. Vol. 3, N 3. doi: 10.4172/2327-4360.1000141

Kumar R.J., Barqawi A.B., Crawford E.D. Epidemiology of prostate cancer // Bus. Brief. US Oncol. Rev. 2004. P. 1–6. doi: 10.17925/OHR.2005.00.00.1f

Maddams J., Brewster D., Gavin A., et al. Cancer prevalence in the United Kingdom: estimates for 2008 // Br. J. Cancer. 2009. Vol. 101, N 3. P. 541–547. doi: 10.1038/sj.bjc.6605148 EDN: YAXGOY

Lutz J.M., Francisci S., Mugno E., et al. Cancer prevalence in Central Europe: the EUROPREVAL Study // Ann. Oncol. 2003. Vol. 14, N 2. P. 313–322. doi: 10.1093/annonc/mdg059 EDN: HOZLOC

Möller T., Anderson H., Aareleid T., et al. Cancer prevalence in Northern Europe: the EUROPREVAL study // Ann. Oncol. 2003. Vol. 14, N 6. P. 946–957. doi: 10.1093/annonc/mdg255 EDN: IKYOLH

De Angelis R., Grande E., Inghelmann R., et al. Cancer prevalence estimates in Italy from 1970 to 2010 // Tumori. 2007. Vol. 93, N 4. P. 392–397. doi: 10.1177/030089160709300411

Jones B.A., Liu W.-L., Araujo A.B., et al. Explaining the race difference in prostate cancer stage at diagnosis // Cancer Epidemiol. Biomarkers Prev. 2008. Vol. 17, N 10. P. 2825–2834. doi: 10.1158/1055-9965.EPI-08-0203

Rebbeck T.R., Haas G.P. Temporal trends and racial disparities in global prostate cancer prevalence // Can. J. Urol. 2014. Vol. 21, N 5. P. 7496–7506.

Qi D., Wu C., Liu F., et al. Trends of prostate cancer incidence and mortality in Shanghai, China from 1973 to 2009 // Prostate. 2015. Vol. 75, N 14. P. 1662–1668. doi: 10.1002/pros.23046

Aune D., Rosenblatt D.A.N., Chan D.S., et al. Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies // Am. J. Clin. Nutr. 2015. Vol. 101, N 1. P. 87–117. doi: 10.3945/ajcn.113.067157

Gallus S., Foschi R., Negri E., et al. Dietary zinc and prostate cancer risk: a case-control study from Italy // Eur. Urol. 2007. Vol. 52, N 4. P. 1052–1056. doi: 10.1016/j.eururo.2007.01.094

Park S.Y., Wilkens L.R., Morris J.S., et al. Serum zinc and prostate cancer risk in a nested case-control study: The multiethnic cohort // Prostate. 2013. Vol. 73, N 3. P. 261–266. doi: 10.1002/pros.22565

Li J., Djenaba J.A., Soman A., et al. Recent trends in prostate cancer incidence by age, cancer stage, and grade, the United States, 2001–2007 // Prostate Cancer. 2012. Vol. 2012. P. 691380. doi: 10.1002/pros.22565

Zaichick V., Zaichick S. Trace element contents in adenocarcinoma of human prostate investigated by energy dispersive X-ray fluorescent analysis // J. Adenocarcinoma. 2016. Vol. 1, N 1. doi: 10.21767/2572-309X.100001

Kwiatek W.M., Hanson A.L., Paluszkiewicz C., et al. Application of SRIXE and XANES to the determination of the oxidation state of iron in prostate tissue sections // J. Alloys Compd. 2004. Vol. 362, N 1–2. P. 83–87. doi: 10.1016/S0925-8388(03)00566-8 EDN: ETFAOP

Генес В.С. Некоторые простые методы кибернетической обработки данных диагностических и физиологических исследований. Москва: Наука, 1967. 208 c.

Патент № 764660 СССР: МПК5 A61B10/00. Заявл. 27.10.1977; опубл. 23.09.1980, Бюлл. № 35. Дунчик В.Н., Жербин Е.А., Зайчик В.Е., и др. Способ дифференциальной диагностики злокачественных и доброкачественных опухолей предстательной железы.

Roberts R.O., Lieber M.M., Rhodes T., et al. Prevalence of a physician-assigned diagnosis of prostatitis: The Olmstead County study of urinary symptoms and health status among men // Urology. 1998. Vol. 51, N 2. P. 578–584. doi: 10.1016/S0090-4295(98)00034-X

Collins M.M., Meigs J.B., Barry M.J., et al. Prevalence and correlates of prostatitis in the health professionals follow-up study cohort // J. Urol. 2002. Vol. 167, N 3. P. 1363–1366. doi: 10.1016/S0022-5347(05)65301-3

Li H.J., Liu J.S., Guo G., et al. Investigation of chronic prostatitis and altered bowel habits // Zhonghua Nan Ke Xue. 2002. Vol. 8, N 5. P. 338–340.

Propert K.J., Litwin M.S., Wang Y., et al. Chronic Prostatitis Collaborative Research Network (CPCRN). Responsiveness of the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) // Qual. Life Res. 2006. Vol. 15, N 2. P. 299–305. doi: 10.1007/s11136-005-1317-1 EDN: KXEMNA

Rodríguez M.A., Afari N., Buchwald D.S. Evidence for overlap between urological and nonurological unexplained clinical conditions // J. Urol. 2009. Vol. 182, N 5. P. 2123–2131. doi: 10.1016/j.juro.2009.07.036

Krieger J.N., Lee S.W., Jeon J., et al. Epidemiology of prostatitis // Int. J. Antimicrob. Agents. 2008. Vol. 31, Suppl. 1. P. S85–S90. doi: 10.1016/j.ijantimicag.2007.08.028

Pavone-Macaluso M. Chronic prostatitis syndrome: a common, but poorly understood condition. Part II // EAU-EBU Update Ser. 2007. Vol. 5, N 1. P. 15–25. doi: 10.1016/j.eeus.2006.10.001 EDN: MHAYHJ

Vicari E., Salemi M., Sidoti G., et al. Symptom severity following Rifaximin and the Probiotic VSL#3 in patients with chronic pelvic pain syndrome (due to inflammatory prostatitis) plus irritable bowel syndrome // Nutrients. 2017. Vol. 9, N 11. P. 1208. doi: 10.3390/nu9111208

Ihsan A.U., Khan F.U., Khongorzul P., et al. Role of oxidative stress in pathology of chronic prostatitis/chronic pelvic pain syndrome and male infertility and antioxidants function in ameliorating oxidative stress // Biomed. Pharmacother. 2018. Vol. 106. P. 714–723. doi: 10.1016/j.biopha.2018.06.139

Zaichick V., Zaichick S. Relations of bromine, iron, rubidium, strontium, and zinc content to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands // Biol. Trace Elem. Res. 2014. Vol. 157, N 3. P. 195–204. doi: 10.1007/s12011-014-9890-1 EDN: SKNYCR

Zaichick V., Zaichick S. Relations of the neutron activation analysis data to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands // Adv. Biomed. Sci. Eng. 2014. Vol. 1, N 1. P. 26–42.

Zaichick V., Zaichick S. Relations of the Al, B, Ba, Br, Ca, Cl, Cu, Fe, K, Li, Mg, Mn, Na, P, S, Si, Sr, and Zn mass fractions to morphometric parameters in pediatric and nonhyperplastic young adult prostate glands // BioMetals. 2014. Vol. 27, N 2. P. 333–348. doi: 10.1007/s10534-014-9716-9 EDN: SKNNOV

Zaichick V., Zaichick S. The distribution of 54 trace elements including zinc in pediatric and nonhyperplastic young adult prostate gland tissues // J. Clin. Lab. Invest. Updates. 2014. Vol. 2, N 1. P. 1–15. doi: 10.14205/2310-9556.2014.02.01.1

Zaichick V., Zaichick S. Androgen-dependent chemical elements of prostate gland // Androl. Gynecol. Curr. Res. 2014. Vol. 2, N 2. doi: 10.4172/2327-4360.1000121

Zaichick V., Zaichick S. Differences and relationships between morphometric parameters and zinc content in nonhyperplastic and hyperplastic prostate glands // BJMMR. 2015. Vol. 8, N 8. P. 692–706. doi: 10.9734/BJMMR/2015/17572

Патент № 997281 СССР: МПК5 A61B10/00. Заявл. 30.03.1981; зарегистр. 14.10.1982. Зайчик В.Е., Цыб А.Ф., Дунчик В.Н., Свиридова Т.В. Способ диагностики заболеваний предстательной железы.

Zaichick V., Zaichick S. Br, Fe, Rb, Sr, and Zn levels in the prostatic secretion of patients with chronic prostatitis // Int. Arch. Urol. Complic. 2018. Vol. 4, N 2. P. 4–6. doi: 10.23937/2469-5742/1510046

Tavani A., Longoni E., Bosetti C., et al. Intake of selected micronutrients and the risk of surgically treated benign prostatic hyperplasia: a case-control study from Italy // Eur. Urol. 2006. Vol. 50, N 3. P. 549–554. doi: 10.1016/j.eururo.2005.11.027 EDN: LOZWLL

Bravi F., Bosetti C., Dal Maso L., et al. Food groups and risk of benign prostatic hyperplasia // Urology. 2006. Vol. 67, N 1. P. 73–79. doi: 10.1016/j.urology.2005.07.030

Galeone C., Pelucchi C., Talamini R., et al. Onion and garlic intake and the odds of benign prostatic hyperplasia // Urology. 2007. Vol. 70, N 4. P. 672–676. doi: 10.1016/j.urology.2007.06.1099

Zaichick V., Zaichick S. Trace element concentrations in the expressed prostatic secretion of normal and hyperplastic prostate // J. Urol. Neph. St. 2018. Vol. 1, N 3. Art. JUNS.MS.ID.000112. doi: 10.32474/JUNS.2018.01.000112

Zaichick V., Zaichick S. Trace elements of expressed prostate secretions as a source for biomarkers of prostate cancer // J. Clin. Res. Oncol. 2018. Vol. 1, N 1. P. 1–7.

Zaichick V., Zaichick S. Significance of trace element quantities in the prostatic secretion of patients with benign prostatic hyperplasia and prostate cancer // J. Cancer Metastasis Treat. 2019. Vol. 5. P. 48. doi: 10.20517/2394-4722.2019.07

Zaichick V., Zaichick S. Using prostatic fluid levels of zinc concentration in non-invasive and highly accurate screening for prostate cancer // J. Can. Ther. 2020. Vol. 11, N 1. P. 1–17. doi: 10.4236/jct.2020.111001 EDN: CNTQBA

Tkac J., Gajdosova V., Hroncekova S., et al. Prostate-specific antigen glycoprofiling as diagnostic and prognostic biomarker of prostate cancer // Interface Focus. 2019. Vol. 9, N 2. P. 20180077. doi: 10.1098/rsfs.2018.0077

Zaichick V., Zaichick S. Population-Based screening for prostate cancer by measuring zinc levels in prostatic fluid // Int. J. Med. Sci. 2020. Vol. 2, N 1. P. 17–24. doi: 10.33545/26648881.2020.v2.i1a.17 EDN: OYGMPM

Catalona W.J., Smith D.S., Ratliff T.L., et al. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer // N. Engl. J. Med. 1991. Vol. 324, N 17. P. 1156–1161. doi: 10.1056/NEJM199104253241702

Красный С.А., Тарендь Д.Т., Семенов С.А. Результаты скрининга рака Предстательной железы и проблема гипердиагностики заболевания в республике беларусь // Онкоурология. 2016. Т. 12, № 1. P. 58–62. doi: 10.17650/1726-9776-2016-12-1-58-62 EDN: WALWJZ

De Koning H.J., Auvinen A., Berenguer Sanchez A., et al. Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial // Int. J. Cancer. 2002. Vol. 97, N 2. P. 237–244. doi: 10.1002/ijc.1588

Heyns C.F., Mathee S., Isaacs A., et al. Problems with prostate specific antigen screening for prostate cancer in the primary healthcare setting in South Africa // BJU Int. 2003. Vol. 91, N 9. P. 785–788. doi: 10.1046/j.1464-410X.2003.04241.x

Catalona W.J. Prostate Cancer Screening // Med. Clin. North Am. 2018. Vol. 102, N 2. P. 199–214. doi: 10.1016/j.mcna.2017.11.001

Li X., Tsuji I., Kuwahara M., et al. Mass screening of prostate cancer in Changchun City of China // Int. Urol. Nephrol. 2004. Vol. 36, N 4. P. 541–548. doi: 10.1007/s11255-004-0842-0

Qu M., Ren S.C., Sun Y.H. Current early diagnostic biomarkers of prostate cancer // Asian J. Androl. 2014. Vol. 16, N 4. P. 549–554. doi: 10.4103/1008-682X.129211

Luboldt H.J., Bex A., Swoboda A., et al. Early detection of prostate cancer in Germany: a study using digital rectal examination and 4.0 ng/ml prostate-specific antigen as cutoff // Eur. Urol. 2001. Vol. 39, N 2. P. 131–137. doi: 10.1159/000052427

Ugwumba F.O., Okoh A.D., Echetabu K.N., et al. Prostate cancer detected by screening in a semi urban community in southeast Nigeria: correlations and associations between anthropometric measurements and prostate-specific antigen // Niger. J. Surg. 2017. Vol. 23, N 1. P. 33–36. doi: 10.4103/1117-6806.199967

Аполихин О.И., Сивков А.В., Катибов М.И., и др. Скрининг рака предстательной железы: оценка с позиции клинико-экономической эффективности // Экспериментальная и клиническая урология. 2015. N 2. С. 20–24. doi: 10.17709/2409-2231-2015-1-77-82 EDN: UGUWPB

Zaichick V., Zaichick S. Effect of age on the Br, Fe, Rb, Sr, and Zn concentrations in human prostatic fluid investigated by energy-dispersive X-ray fluorescent microanalysis // MicroMed. 2018. Vol. 6, N 2. P. 94–104. doi: 10.5281/zenodo.1447214

Rossmann M., Zaichick S., Zaichick V. Determination of key chemical elements by energy dispersive X-Ray fluorescence analysis in commercially available infant and toddler formulas consumed in UK // Nutr. Food Technol. Open Access. 2016. Vol. 2, N 4. P. 1–7. doi: 10.16966/2470-6086.130

Zapała P., Dybowski B., Poletajew S., Radziszewski P. What can be expected from prostate cancer biomarkers: A clinical perspective // Urol. Int. 2018. Vol. 100, N 1. P. 1–12. doi: 10.1159/000479982 EDN: VEDBSM

Sorokin I., Mian B.M. Risk calculators and updated tools to select and plan a repeat biopsy for prostate cancer detection // Asian J. Androl. 2015. Vol. 17, N 6. P. 864–869. doi: 10.4103/1008-682X.156859 EDN: VEIVOB

Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter // N. Engl. J. Med. 2004. Vol. 350, N 22. P. 2239–2246. doi: 10.1056/NEJMoa031918

Alotaibi K.M. Incidence of prostate cancer among patients with prostate-related urinary symptoms: A single institution series in 10 years // Urol. Ann. 2019. Vol. 11, N 2. P. 135–138. doi: 10.4103/UA.UA_151_18 EDN: HCDJPE

Whelan C., Crocitto L., Kawachi M., et al. The influence of PSA-RNA yield on the analysis of expressed prostatic secretions (EPS) for prostate cancer diagnosis // Can. J Urol. 2013. Vol. 20, N 1. P. 6597–6602.

Hayes B., Murphy C., Crawley A., O’Kennedy R. Developments in point-of-care diagnostic technology for cancer detection // Diagnostics (Basel). 2018. Vol. 8, N 2. P. 39. doi: 10.3390/diagnostics8020039

Hjertholm P., Fenger-Gron M., Vestergaard M., et al. Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study // Int. J. Cancer. 2015. Vol. 136, N 2. P. 435–442. doi: 10.1002/ijc.29008

Swartz H.M., Williams B.B., Flood A.B. Overview of the principles and practice of biodosimetry // Radiat. Environ. Biophys. 2014. Vol. 53, N 2. P. 221–232. doi: 10.1007/s00411-014-0522-0 EDN: VTMMAB

Bhat N.N., Chaurasia R., Yadav U., Sapra B.K. Biodosimetry techniques and the biological indicators of radiation exposure in humans // BARC Newsletter. 2018. N 365. P. 22–30. Available from: https://inis.iaea.org/records/tdzz1-pd359

He X., Swarts S.G., Demidenko E., et al. Development and validation of an ex vivo electron paramagnetic resonance fingernail biodosimetric method // Radiat. Prot. Dosimetry. 2014. Vol. 159, N 1–4. P. 172–181. doi: 10.1093/rpd/ncu129

Ryan T.I., Pantelias A.G., Terzoudi G.I., et al. Use of human lymphocyte G0 PCCs to detect intra- and inter-chromosomal aberrations for early radiation biodosimetry and retrospective assessment of radiation-induced effects // PLoS One. 2019. Vol. 14, N 5. P. e0216081. doi: 10.1371/journal.pone.0216081 EDN: XKPPYS

Zaichick S., Zaichick V. Trace elements of normal, benign hypertrophic and cancerous tissues of the human prostate gland investigated by neutron activation analysis // Appl. Radiat. Isot. 2012. Vol. 70, N 1. P. 81–87. doi: 10.1016/j.apradiso.2011.08.021 EDN: PDGION

Zaichick V., Zaichick S. Trace element levels in prostate gland as carcinoma’s marker // J. Cancer Ther. 2017. Vol. 8, N 2. P. 131–145. doi: 10.4236/jct.2017.82011

Будагов Р.С., Ашуров А.А., Зайчик В.Е. Микроэлементы крови как индикатор степени тяжести лучевых поражений // Радиобиология. 1994. Т. 34, № 1. С. 49–54.

Zhang J., Yao D., Song Y., et al. Fractionated irradiation of right thorax induces abscopal damage on testes leading to decline in fertility // Sci. Rep. 2019. Vol. 9, N 1. P. 15221. doi: 10.1038/s41598-019-51772-y

Littley M.D., Shalet S.M., Morgenstern G.R., Deakin D.P. Endocrine and reproductive dysfunction following fractionated total body irradiation in adults // Q. J. Med. 1991. Vol. 78, N 287. P. 265–274. EDN: JIYUCV

Ogilvy-Stuart A.L., Shalet S.M. Effect of radiation on the human reproductive system // Environ. Health Perspect. 1993. Vol. 101, Suppl 2. P. 109–116. doi: 10.1289/ehp.93101s2109

Kesari K.K., Agarwal A., Henkel R. Radiations and male fertility // Reprod. Biol. Endocrinol. 2018. Vol. 16, N 1. P. 118. doi: 10.1186/s12958-018-0431-1 EDN: WXBBXX

Poorvu P.D., Frazier A.L., Feraco A.M., et al. Cancer treatment-related infertility: A critical review of the evidence // JNCI Cancer Spectr. 2019. Vol. 3, N 1. P. pkz008. doi: 10.1093/jncics/pkz008

Zaichick V., Zaichick S. Preliminary study of prostatic fluid levels of zinc concentration as the biodosimeter of males exposure to ionizing radiation // Acta Sci. Med. Sci. 2020. Vol. 4, N 3. P. 01–07. doi: 10.31080/asms.2020.04.0555 EDN: XJZPOV

Zaichick V., Zaichick S. A systematic review of the zinc concentrations in the prostate fluid of normal gland // Acta Sci. Med. Sci. 2020. Vol. 4, N 1. P. 82–89. Available from: https://actascientific.com/ASMS/pdf/a-systematic-review-of-the-zinc-concentrations-in-the-prostate-fluid-of-normal-gland.pdf

Севанькаев А.В., Насонов А.П. Биологическая дозиметрия хромосомных аберраций культуры лимфоцитов человека. Методические рекомендации. Обнинск: Медицинский радиологический научный центр, 1979.

Rana S., Kumar R., Sultana S., Sharma R.K. Radiation-induced biomarkers for the detection and assessment of absorbed radiation doses // J. Pharm. Bioall. Sci. 2010. Vol. 2, N 3. P. 189–196. doi: 10.4103/0975-7406.68500

Патент № 997536 СССР; МПК5 G01T1/161. Заявл. 20.07.1981; зарегистр. 14.10.1982. Зайчик В.Е., Цыб А.Ф., Свиридова Т.В., Дунчик В.Н. Способ биологической дозиметрии.

Tipton J.H., Steiner R.L., Foland W.D., et al. USAEC-ORNL-Report-CF-54-12-66. 1954.

Koch H.J., Smith E.R., Shimp N.F., Connor J. Analysis of trace elements in tissue. I. Normal tissue // Cancer. 1956. Vol. 9, N 3. P. 499–511. doi: 10.1002/1097-0142(195605/06)9:3<499::AID-CNCR2820090311>3.0.CO;2-1

ICRP (International Commission on Radiological Protection). Report of Committee III on Protection Against X-rays up to Energies of 3 MeV and Beta- and Gamma-rays from Sealed Sources. ICRP Publication 3. Oxford: Pergamon Press, 1960.

Kerr W.K., Keresteci A.G., Mayon H. The distribution of zinc within the human prostate // Cancer. 1960. Vol. 13. P. 550–554. doi: 10.1002/1097-0142(196005/06)13:3<550::AID-CNCR2820130320>3.0.CO;2-X

Shirakawa T. Clinical and experimental study on quantitative analysis of zinc in prostate // Acta Urol. Jap. 1961. Vol. 7. P. 352–362.

Закутинский Д.И., Парфенов Ю.Д., Селиванова Л.Н. Справочник по токсикологии радиоактивных изотопов. Москва: Медгиз, 1962. 116 с.

Tipton I.H., Cook M.J. Trace elements in human tissue. Part II. Adult subjects from the United States // Health Phys. 1963. Vol. 9. P. 103–145. doi: 10.1097/00004032-196302000-00002

Schrodt G.R., Hall T., Whitmore W.R.Jr. The concentration of zinc in diseased human prostate glands // Cancer. 1964. Vol. 17. P. 1555–1566. doi: 10.1002/1097-0142(196412)17:12<1555::AID-CNCR2820171207>3.0.CO;2-U

Sangen H. The influence of the trace metals upon the aconitase activity in human prostate glands // Nihon Hinyokika Gakkai Zasshi. 1967. Vol. 58. P. 1146–1159. doi: 10.5980/jpnjurol1928.58.11_1146

Schroeder H.A., Nason A.P., Tipton I.H., Balassa J.J. Essential trace metals in man: Zinc. Relation to environmental cadmium // J. Chron. Dis. 1967. Vol. 20, N 4. P. 179–210. doi: 10.1016/0021-9681(67)90002-1

Liebscher K., Smith H. Essential and nonessential trace elements. A method of determining whether an element is essential or nonessential in human tissue // Arch. Environ. Health. 1968. Vol. 17, N 6. P. 882–891. doi: 10.1080/ 00039896.1968.10665346

Mikac-Devic D. Methodology of zinc determinations and the role of zinc in biochemical processes // Adv. Clin. Chem. 1970. Vol. 13. P. 271–333. doi: 10.1016/S0065-2423(08)60388-1

Schneider H.-J., Anke M., Holm W. The inorganic components of testicle, epididymis, seminal vesicle, prostate and ejaculate of young men // Int. Urol. Nephrol. 1970. Vol. 2. P. 419–427. doi: 10.1007/BF02081698

Soman S.D., Joseph K.T., Raut S.J., et al. Studies of major and trace element content in human tissues // Health Phys. 1970. Vol. 19, N 5. P. 641–656. doi: 10.1097/00004032-197011000-00006

Holm W., Schneider H.-J., Anke M. Der Mineralstoffgehalt des Ejakulates und seine Beziehung zum Mengen- und Spurenelementgehalt von Prostate, Samenblase, Nebenhoden und Hoden // Arch. Exper. Vet. Med. 1971. Vol. 25, N 5. P. 811–815.

Boström K., Andersson L. Creatine phosphokinase relative to acid phosphatase, lactate dehydrogenase, zinc and fructose in human semen with special reference to chronic prostatitis // Scand. J. Urol. Nephrol. 1971. Vol. 5, N 2. P. 123–132. doi: 10.3109/00365597109133590

Forssen A. Inorganic elements in the human body. I. Occurrence of Ba, Br, Ca, Cd, Cs, Cu, K, Mn, Ni, Sn, Sr, Y and Zn in the human body // Ann. Med. Exp. Biol. Fenn. 1972. Vol. 50, N 3. P. 99–162.

Lindholmer C., Glaumann H. Zinc and magnesium in human male reproductive tract // Andrologie. 1972. Vol. 4, N 3. P. 231–237. doi: 10.1111/j.1439-0272.1972.tb01549.x

Anspaugh L.R., Robinson W.L., Martin W.H., Lowe O.A. Compilation of published information on elemental concentrations in human organs in both normal and diseased states. No. UCRL-51013Pt. 1971–1973. P. 1–4.

Müntzing J., Nilson T., Polasek J. Zinc and β-glucuronidase in human prostate // Scand. J. Urol. Nephrol. 1974. Vol. 8, N 2. P. 87–90. doi: 10.3109/ 00365597409132110

Kubo H., Hashimoto S., Ishibashi A., et al. Simultaneous determinations of Fe, Cu, Zn, and Br concentrations in human tissue sections // Med. Phys. 1976. Vol. 3, N 4. P. 204–209. doi: 10.1118/1.594233

Hienzsch E., Schneider H.J., Anke M., et al. The cadmium-, zinc-, copper-, and manganese- level of different organs of human beings without considerable Cd-exposure independence on age and sex // Kadmiumsymposium. Anke M., Schneider H.J. Eds. Jena: Friedrich-Schiller-Universität, 1979. P. 276–282.

Maganto P.E. Zinc levels in the normal and pathological prostate tissue // Actas. Urol. Esp. 1980. Vol. 4, N 1. P. 15–20.

Marezynska A., Kulpa J., Lenko J. The concentration of zinc in relation to fundamental elements in the diseased human prostate // Int. Urol. Nephrol. 1983. Vol. 15, N 3. P. 257–265. doi: 10.1007/BF02083012

Feustel A., Wennrich R. Zinc and cadmium in cell fractions of prostatic cancer tissue of different histological grading in comparison to BPH and normal prostate // Urol. Res. 1984. Vol. 12, N 2. P. 147–150. doi: 10.1007/BF00257182

Lahtonen R. Zinc and cadmium concentrations in whole tissue and in separated epithelium and stroma from human benign prostatic hypertrophic glands // Prostate. 1985. Vol. 6, N 2. P. 177–183. doi: 10.1002/pros.2990060208

Wennrich R., Feustel A. Determination of cadmium and zinc in human prostatic tissues by flameless AAS // Z. Med. Lab. Diagn. 1985. Vol. 26, N 7. P. 365–369.

Feustel A., Wennrich R., Dittrich H. Zinc, cadmium and selenium concentrations in separated epithelium and stroma from prostatic tissues of different histology // Urol. Res. 1987. Vol. 15, N 3. P. 161–163. doi: 10.1007/bf00254429 EDN: JMQVCB

Ogunlewe J.O., Osegbe D.N. Zinc and cadmium concentrations in indigenous blacks with normal, hypertrophic, and malignant prostate // Cancer. 1989. Vol. 63, N 7. P. 1388–1392. doi: 10.1002/1097-0142(19890401)63:7<1388::AID-CNCR2820630725>3.0.CO;2-M

Saltzman B.E., Gross S.B., Yeager D.W., et al. Total body burdens and tissue concentrations of lead, cadmium, copper, zinc, and ash in 55 human cadavers // Environ. Res. 1990. Vol. 52, N 2. P. 126–145. doi: 10.1016/S0013-9351(05)80248-8

Borowiec D., Spruch T., Juszkiewicz M. The measurements of the selected trace element levels in the prostate // Urol. Pol. 1995. Vol. 48. P. 1–5.

Brys M., Nawrocka A.D., Miekos E., et al. Zinc and cadmium analysis in human prostate neoplasmas // Biol. Trace Elem. Res. 1997. Vol. 59. P. 145–152. doi: 10.1007/bf02783239 EDN: KDKDLF

Zaichick V., Sviridova T., Zaichick S. Zinc in human prostate gland: normal, hyperplastic and cancerous // J. Radioanal. Nucl. Chem. 1997. Vol. 217, N 2. P. 157–161. doi: 10.1007/BF02034434 EDN: LEINSP

Banaś A., Kwiatek W.M., Zając W. Trace element analysis of tissue section by means of synchrotron radiation: the use of GNUPLOT for SPIXE spectra analysis // J. Alloys Compd. 2001. Vol. 328, N 1–2. P. 135–138. doi: 10.1016/S0925-8388(01)01334-2 EDN: AREMVF

Kwiatek W.M., Banas A., Gajda M., et al. Cancerous tissues analyzed by SRIXE // J. Alloys Compd. 2005. Vol. 401, N 1–2. P. 173–177. doi: 10.1016/j.jallcom.2005.02.070 EDN: KMBGJL

Kwiatek W.M., Banas A., Banas K., et al. Distinguishing prostate cancer from hyperplasia // Acta Phys. Pol. 2006. Vol. 109, N 3. P. 377–381. doi: 10.12693/APhysPolA.109.377

Cortesi M., Fridman E., Volkov A., et al. Clinical assessment of the cancer diagnostic value of prostatic zinc: a comprehensive needle-biopsy study // Prostate. 2008. Vol. 68, N 9. P. 994–1006. doi: 10.1002/pros.20766 EDN: XHJJST

Sarafanov A.G., Todorov T.I., Kajdacsy-Balla A., et al. Analysis of iron, zinc, selenium and cadmium in paraffin-embedded prostate tissue specimens using inductively coupled plasma mass-spectrometry // J. Trace Elem. Med. Biol. 2008. Vol. 22, N 4. P. 305–314. doi: 10.1016/j.jtemb.2008.03.010

Tohno S., Kobayashi M., Shimizu H., et al. Age-related changes of the concentrations of select elements in the prostates of Japanese // Biol. Trace Elem. Res. 2009. Vol. 127, N 3. P. 211–227. doi: 10.1007/s12011-008-8241-5

Cortesi M., Fridman E., Volkov A., et al. New prospective for non-invasive detection, grading, size evaluation, and tumor location of prostate cancer // Prostate. 2010. Vol. 70, N 15. P. 1701–1708. doi: 10.1002/pros.21205 EDN: OKQNKB

Christudoss P., Selvakumar R., Fleming J.J., et al. Zinc status of patients with benign prostatic hyperplasia and prostate carcinoma // Indian J. Urol. 2011. Vol. 27, N 1. P. 14–18. doi: 10.4103/0970-1591.78405 EDN: OKQNMT

Leitão R.G., Palumbo A., Souza P.A.V.R., et al. Elemental concentration analysis in prostate tissues using total reflection X-ray fluorescence // Radiat. Phys. Chem. 2014. Vol. 95. P. 62–64. doi: 10.1016/j.radphyschem.2012.12.044 EDN: SQXDGN

Neslund-Dudas C., Kandegedara A., Kryvenko O.N., et al. Prostate tissue metal levels and prostate cancer recurrence in smokers // Biol. Trace Elem. Res. 2014. Vol. 157, N 2. P. 107–112. doi: 10.1007/s12011-013-9874-6 EDN: SPXINH

Zaichick S., Zaichick V. EDXRF determination of trace element contents in benign prostatic hypertrophic tissue // Fundamental Interactions and Neutrons, Neutron Spectroscopy, Nuclear Structure, Ultracold Neutrons, Related Topics. Dubna: Joint Institute for Nuclear Research, 2014. P. 311–316.

Zaichick V., Zaichick S., Davydov G. Differences between chemical element contents in hyperplastic and nonhyperplastic prostate glands investigated by neutron activation analysis // Biol. Trace Elem. Res. 2015. Vol. 164, N 1. P. 25–35. doi: 10.1007/s12011-014-0204-4 EDN: UFQGKR

Rossmann M., Zaichick S., Zaichick V. Distinguishing malignant from benign prostate tumors using Br, Fe, Rb, Sr, and Zn content in prostatic tissue // Integr. Mol. Med. 2016. Vol. 1. P. 1054. doi: 10.15761/IMM.1000234

Zaichick V., Zaichick S. Trace element contents in adenocarcinoma of the human prostate gland investigated by neutron activation analysis // Cancer Res. Oncol. 2016. Vol. 1. P. 002. Available from: https://api.semanticscholar.org/CorpusID:27913910

Zaichick V., Zaichick S. The comparison between the contents and interrelationships of 17 chemical elements in normal and cancerous prostate gland // JPS. Open Access. 2016. Vol. 1, N 1. P. 1–10.

Zaichick V., Zaichick S. Prostatic tissue level of some major and trace elements in patients with BPH // J. Nephro. Urol. 2016. Vol. 3, N 1. P. 1–10.

Zaichick V., Zaichick S. Distinguishing malignant from benign prostate using content of 17 chemical elements in prostatic tissue // Integr. Cancer Sci. Therap. 2016. Vol. 3, N 5. P. 579–587. doi: 10.15761/ICST.1000208

Zaichick S., Zaichick V. Prostatic tissue levels of 43 trace elements in patients with BPH // Br. J. Med. & Med. Res. 2016. Vol. 15, N 2. P. 1–12. doi: 10.9734/BJMMR/2016/25275

Zaichick V., Zaichick S. Prostatic tissue levels of 43 trace elements in patients with prostate adenocarcinoma // Can. Clin. Oncol. 2016. Vol. 5, N 1. P. 79–94. doi: 10.5539/cco.v5n1p79

Zaichick V., Zaichick S. Variations in concentration and distribution of several androgen-dependent and independent trace elements in nonhyperplastic prostate gland tissue throughout adulthood // J. Androl. Gynaecol. 2016. Vol. 4, N 1. P. 1–10.

Zaichick V., Zaichick S. Variations in concentration and histological distribution of Ag, Co, Cr, Fe, Hg, Rb, Sb, Sc, Se, and Zn in nonhyperplastic prostate gland throughout adulthood // J. J. Cell. Mol. Bio. 2016. Vol. 2, N 1. P. 011. Available from: http://molecularbiology.jacobspublishers.com/images/Cell/J_J_Cell_Mol_Bio_2_1_011.pdf

Zaichick V., Zaichick S. Age-related changes in concentration and histological distribution of 18 chemical elements in nonhyperplastic prostate of adults // World J. Pharm. Med. 2016. Vol. 2, N 2. P. 5–18. Available from: https://www.wjpmr.com/home/article_abstract/102

Zaichick V., Zaichick S. Age-related changes in concentration and histological distribution of 54 trace elements in nonhyperplastic prostate of adults // Int. Arch. Urol. Complic. 2016. Vol. 2, N 2. P. 019. doi: 10.23937/2469-5742/1510019

Zaichick V., Zaichick S. Chemical element contents in normal and benign hyperplastic prostate // Ann. Mens Health Wellness. 2017. Vol. 1, N 2. P. 1006. Available from: https://www.jscimedcentral.com/article-pdf/-Annals-of-Mens-Health-and-Wellness/menshealth-1-1006.pdf

Zaichick V. Differences between 66 chemical element contents in normal and cancerous prostate // J. Anal. Oncol. 2017. Vol. 6. P. 37–56. doi: 10.6000/1927-7229.2017.06.02.1

Zaichick V., Zaichick S. Comparison of 66 chemical element contents in normal and benign hyperplastic prostate // Asian. J. Urol. 2019. Vol. 6. N 3. P. 275–289. doi: 10.1016/j.ajur.2017.11.009 EDN: YAZYAY

Daragó A., Klimczak M., Stragierowicz J., et al. Age-related changes in zinc, copper and selenium levels in the human prostate // Nutrients. 2021. Vol. 13, N 5. P. 1403. doi: 10.3390/nu13051403 EDN: NDOAUB

Zaichick V. A systematic review of the zinc content of the normal human prostate gland // Biol. Trace. Elem. Res. 2021. Vol. 199, N 10. P. 3593–3607. doi: 10.1007/s12011-020-02495-z EDN: FJTUPX

Zaichick V., Wynchank S. Reference man for radiological protection: 71 chemical elements’ content of the prostate gland (normal and cancerous) // Radiat. Environ. Biophys. 2021. Vol. 60. P. 165–178. doi: 10.1007/s00411-020-00884-5 EDN: WMPWJH

Habib F.K., Leake A., Beynon L., et al. Studies on the relationship between zinc and androgens in the human prostate // Adv Urol Oncol Endocrinol (Rome). 1984. P. 143–150.

Zaichick V., Zaichick S. Role of zinc in prostate cancerogenesis // Mengen und Spurenelemente. 19. Arbeitstagung. Jena: Friedrich-Schiller-Universitat, 1999. P. 104–115.

Zaichick V., Zaichick S., Wynchank S. Intracellular zinc excess as one of the main factors in the etiology of prostate cancer // J Anal Oncol. 2016. Vol. 5, N 5. P. 124–131. doi: 10.6000/1927-7229.2016.05.03.5 EDN: XFHRFH

Zaichick V., Tsyb A., Matveenko E., et al. Instrumental neutron activation analysis of essential and toxic elements in the child and adolescent diets in the Chernobyl disaster territories of the Kaluga Region // Sci Total Environ. 1996. Vol. 192. P. 269–274. doi: 10.1016/S0048-9697(96)05321-1 EDN: LDWJRR

Kothar R.P., Chaudhari A.R. Zinc levels in seminal fluid in infertile males and its relation with serum free testosterone // J Clin Diagn Res. 2016. Vol. 10, N 5. P. CC05–CC08. doi: 10.7860/JCDR/2016/14393.7723

Zhao J., Dong X., Hu X., et al. Zinc levels in seminal plasma and their correlation with male infertility: A systematic review and meta-analysis // Sci Rep. 2016. Vol. 6. P. 22386. doi: 10.1038/srep22386 EDN: WVDEVD

Kerns K., Zigo M., Sutovsky P. Zinc: a necessary ion for mammalian sperm fertilization competency // Int J Mol Sci. 2018. Vol. 19, N 12. P. 4097. doi: 10.3390/ijms19124097 EDN: FRQPXA

López-Botella A., Sánchez R., Paul R., et al. Analytical determination of heavy metals in human seminal plasma-a systematic review // Life (Basel). 2023. Vol. 13, N 4. P. 925. doi: 10.3390/life13040925 EDN: NOXXLD

Gonic P., Oberleas D., Knechtges T., et al. Atomic absorption determination of zinc in the prostate // Invest Urol. 1969. Vol. 6, N 4. P. 345–347.

Wallace A.M., Grant J.K. Effect of zinc on androgen metabolism in the human hyperplastic prostate // Biochem Soc Trans. 1975. Vol. 3, N 4. P. 540–542. doi: 10.1042/bst0030540

Sinquin G., Morfin R., Charles J.F., et al. Testosterone metabolism by homogenates of human prostates with benign hyperplasia: Effect of tissular concentration of zinc, magnesium and copper // J Steroid Biochem. 1982. Vol. 17, N 4. P. 395–400. doi: 10.1016/0022-4731(82)90632-X

Vartsky D., Shilstein S., Bercovich A., et al. Prostatic zinc and prostate specific antigen: An experimental evaluation of their combined diagnostic value // J Urol. 2003. Vol. 170, N 6 Pt 1. P. 2258–2262. doi: 10.1097/01.ju.0000095795.86327.b8 EDN: LOZVOT

Yaman M., Atici D., Bakirdere S., et al. Comparison of trace metal concentrations in malignant and benign human prostate // J Med Chem. 2005. Vol. 48, N 2. P. 630–634. doi: 10.1021/jm0494568

Chen Y.C., Sung F.C. The distribution of cadmium and zinc in tissues of prostate carcinoma and BPH // Epidemiology. 2006. Vol. 17, N 6. P. S487. doi: 10.1097/ 00001648-200611001-01307

Shilstein S.S., Cortesi M., Breskin A., et al. Prostatic Zn determination for prostate cancer diagnosis // Talanta. 2006. Vol. 70, N 5. P. 914–921. doi: 10.1016/j.talanta.2006.05.053 EDN: LOZWMP

Leitão RG, Anjos M J, Canellas CGL, et al. Elemental concentration analysis in PCa, BPH and normal prostate tissues using SR-TXRF. Report on International Nuclear Atlantic Conference - INAC 2009, Rio de Janeiro,RJ, Brazil, September27 to October 2, 2009/ ISBN: 978-85-99141-03-8. Available from: https://inis.iaea.org/records/112e9-j2z84

Lopes R.T., Lima I., Pereira G.R., et al. Synchrotron radiation X-ray microfluorescence techniques and biological applications // Pramana J. Phys. 2011. Vol. 76, N 2. P. 271–279. doi: 10.1007/s12043-011-0043-1

Singh B.P., Dwivedi S., Dhakad U., et al. Status and interrelationship of zinc, copper, iron, calcium and selenium in prostate cancer // Indian J. Clin. Biochem. 2016. Vol. 31, N 1. P. 50–56. doi: 10.1007/s12291-015-0497-x EDN: WTWEXJ

Nickel J.C. Prostatitis // Can Urol Assoc J. 2011. Vol. 5, N 5. P. 306–315. doi: 10.5489/cuaj.11211

Lim K.B. Epidemiology of clinical benign prostatic hyperplasia // Asian J. Urol. 2017. Vol. 4, N 3. P. 148–151. doi: 10.1016/j.ajur.2017.06.004

Siegel R.L., Miller K.D., Jemal A. Cancer Statistics, 2017 // CA Cancer J. Clin. 2017. Vol. 67, N 1. P. 7–30. doi: 10.3322/caac.21387

Sharma S., Zapatero-Rodríguez J., O’Kennedy R. Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools // Biotechnol Adv. 2017. Vol. 35, N 2. P. 135–149. doi: 10.1016/j.biotechadv.2016.11.009

Zaichick V. A systematic review of the zinc content of the hyperplastic human prostate gland // Biomed. Res. Trace Elem. 2020. Vol. 31, N 3. P. 98–116. doi: 10.11299/brte.31.98

Paluszkiewicz C., Kwiatek W. Analysis of human cancer prostate tissue using FTIR microspectroscopy and SRIXE techniques // J Mol Struct. 2001. Vol. 565–566. P. 329–334. doi: 10.1016/S0022-2860(01)00527-0 EDN: KSTSSE

Eckhert C.D. Microlocalization and quantitation of risk associated elements in Gleason graded prostate tissue. Annual Report (1 Mar 2004 — 28 Feb 2005) NSN 7540-01-280-5500, University of California, Los Angeles, CA 90024, 2005. Available from: https://apps.dtic.mil/sti/html/tr/ADA463233/index.html

Зайчик В. Радионуклидная рентгено-флуоресценция для элементного анализа в клинической медицине. В сб. III Совещание по использованию новых ядерно-физических методов для решения научно-технических и народно-хозяйственных задач (Дубна, 12–15 сентября 1978 г.). Дубна, Объединенный институт ядерных исследований, 1979, c. 243–246.

Zaichick V. A systematic review of the zinc content of the cancerous human prostate gland // Biomed. Res. Trace Elem. 2021. Vol. 32, N 1. P. 1–15. doi: 10.11299/brte.32.1

Leitzmann M.F., Rohrmann S. Risk factors for the onset of prostatic cancer: age, location, and behavioral correlates // Clin Epidemiol. 2012. Vol. 4. P. 1–11. doi: 10.2147/CLEP.S16747

Lee J.J., Thomas J.-C., Nolley R., et al. Biologic differences between peripheral and transition zone prostate cancer // Prostate. 2015. Vol. 75, N 2. P. 183–190. doi: 10.1002/pros.22903

Abudoubari S., Bu K., Maimaitiyiming A., et al. Prostate cancer epidemiology and prognostic factors in the United States // Front. Oncol. 2023. Vol. 13. P. 1142976. doi: 10.3389/fonc.2023.1142976 EDN: MNWWDP

Kadeerhan G., Xue B., Wu X.L., et al. Incidence trends and survival of metastatic prostate cancer with bone and visceral involvement: 2010–2019 surveillance, epidemiology, and end results // Front. Oncol. 2023. Vol. 13. P. 1201753. doi: 10.3389/fonc.2023.1201753 EDN: FSHKMO

Birnbaum D., Hall T., Lee R. Zinc content of rat sperm cells from ejaculate, vas, spididymis and testis // Proc. Soc. Exp. Biol. Med. 1961. Vol. 108. P. 321–324. doi: 10.3181/00379727-108-26926

Anderson R.U., Fair W.R. Physical and chemical determinations of prostatic secretion in benign hyperplasia, prostatitis, and adenocarcinoma // Invest. Urol. 1976. Vol. 14, N 2. P. 137–140.

Fair W.R., Couch J., Wehner N. Prostatic antibacterial factor. Identity and significance // Urology. 1976. Vol. 7, N 2. P. 169–177. doi: 10.1016/0090-4295(76)90305-8

Paz G., Sofer A., Homonnai Z.T., et al. Human semen analysis. Seminal plasma and prostatic fluid composition and their interrelations with sperm quality // Int. J. Fertil. 1977. Vol. 22, N 3. P. 140–147.

Zaneveld L.J.D., Tauber P.F. Contribution of prostatic fluid components to the ejaculate // Prostatic Cell: Structure and Function. New York: Alan R. Liss, 1981. Part A. P. 265–277.

Kavanagh J.P. Zinc binding properties of human prostatic tissue, prostatic secretion and seminal fluid // J. Reprod. Fertil. 1983. Vol. 68, N 2. P. 359–363. doi: 10.1530/jrf.0.0680359

Cui D., Han G.W., Shang Y.G., et al. The effect of chronic prostatitis on zinc concentration of prostatic fluid and seminal plasma: a systematic review and meta-analysis // Curr Med Res Opin. 2015. Vol. 31, N 9. P. 1763–1769. doi: 10.1185/03007995.2015.1072707 EDN: WOJNQP

Zaichick V., Zaichick S. Method and portable facility for measurement of trace element concentration in prostate fluid samples using radionuclide-induced energy-dispersive X-ray fluorescent analysis // Nuclear Science and Technology. 2016. Vol. 27, N 6. P. 136. doi: 10.1007/s41365-016-0133-3 EDN: XFMGWL

Smith C.P. Male chronic pelvic pain: An update // Indian J. Urol. 2016. Vol. 32, N 1. P. 34–39. doi: 10.4103/0970-1591.173105

Chen Y., Li J., Hu Y., et al. Multi-factors including inflammatory/immune, hormones, tumor-related proteins and nutrition associated with chronic prostatitis NIH IIIa+b and IV based on FAMHES project // Sci. Rep. 2017. Vol. 7, N 1. P. 9143. doi: 10.1038/s41598-017-09751-8

Zaichick V., Zaichick S. A systematic review of the zinc concentrations in the prostate fluid of normal and inflamed gland // Int. J. Innov. Res. Med. Sci. 2019. Vol. 4, N 12. P. 718–724. doi: 10.23958/ijirms/vol04-i12/806

Lu S.-H., Chen C.-S. Natural history and epidemiology of benign prostatic hyperplasia // Formosan J. Surg. 2014. Vol. 47, N 6. P. 207–210. doi: 10.1016/j.fjs.2014.10.001

Patel N.D., Parsons J.K. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction // Indian J. Urol. 2014. Vol. 30. P. 170–176. doi: 10.4103/0970-1591.126900

Almarkhan M.H., Sawma A.I., Alruwaili F.S., et al. Prevalence of benign prostatic hyperplasia (BPH) in Saudi patients above 40 years old // Egypt. J. Hosp. Med. 2018. Vol. 70, N 7. P. 1137–1139. doi: 10.12816/0044539

Hata J., Harigane Y., Matsuoka K., et al. Mechanism of androgen-independent stromal proliferation in benign prostatic hyperplasia // Int J Mol Sci. 2023. Vol. 24, N 14. P. 11634. doi: 10.3390/ijms241411634 EDN: ZFJZMA

Tong Y., Zhou R.Y. Review of the roles and interaction of androgen and inflammation in benign prostatic hyperplasia // Mediators Inflamm. 2020. Vol. 2020, N 1. P. 7958316. doi: 10.1155/2020/7958316 EDN: OHZBNN

Grigorescu R., Gruia M.I., Nacea V., et al. Parameters of oxidative stress variation depending on the concentration of inorganic zinc compounds // J. Med. Life. 2015. Vol. 8, N 4. P. 449–451.

Schrauzer G.N. Antioxidant supplementation increases skin cancer risk, or, why zinc should not be considered an antioxidant // J. Nutr. 2008. Vol. 138, N 4. P. 820. doi: 10.1093/jn/138.4.820

Habib F.K., Goodman C.M., Buck C. Androgen concentrations in expressed prostatic secretions: no correlation with tissue levels // Urol. Res. 1992. Vol. 20, N 4. P. 281–284. doi: 10.1007/BF00300259

Zaichick V., Zaichick S. A systematic review of the zinc concentrations in the prostate fluid of normal and hyperplastic gland // J. Med. Biomed. App. Sci. 2019. Vol. 7, N 12. P. 303–311.

Taitt H.E. Global trends and prostate cancer: A review of incidence, detection, and mortality as influenced by race, ethnicity, and geographic location // Am. J. Mens Health. 2018. Vol. 12, N 6. P. 1807–1823. doi: 10.1177/1557988318798279 EDN: QTCVMG

Dasgupta P., Baade P.D., Aitken J.F., et al. Geographical variations in prostate cancer outcomes: a systematic review of international evidence // Front. Oncol. 2019. Vol. 9. P. 238. doi: 10.3389/fonc.2019.00238

Sekhoacha M., Riet K., Motloung P., et al. Prostate Cancer Review: Genetics, Diagnosis, Treatment Options, and Alternative Approaches // Molecules. 2022. Vol. 27, N 17. P. 5730. doi: 10.3390/molecules27175730 EDN: TBIWFE

Williams I.S., McVey A., Perera S., et al. Modern paradigms for prostate cancer detection and management // Med. J. Aust. 2022. Vol. 217, N 8. P. 424–433. doi: 10.5694/mja2.51722 EDN: RSLFJR

Zaichick V., Zaichick S. A systematic review of the zinc concentrations in the prostate fluid of normal and cancerous gland // J. Clin. Res. Oncol. 2019. Vol. 2, N 2. P. 1–8.

Zaichick V., Tsyb A., Bagirov Sh. Neutron activation analysis of saliva: Application in clinical chemistry, environmental and occupational toxicology // J. Radioanal. Nucl. Chem. 1995. Vol. 195, N 1. P. 123–132. doi: 10.1007/BF02036481 EDN: SFUAZV

Dong L., Zhang Y., Fu B., et al. Reliable biological and multi-omics research through biometrology // Anal. Bioanal. Chem. 2024. Vol. 416. P. 3645–3663. doi: 10.1007/s00216-024-05239-3 EDN: CBTKSK

Rigo-Bonnin R., Díaz-Troyano N., García-Tejada L., et al. Estimation of the measurement uncertainty and practical suggestion for the description of the metrological traceability in clinical laboratories // Biochem. Med. (Zagreb). 2021. Vol. 31, N 1. P. 010501. doi: 10.11613/bm.2021.010501 EDN: FQJWNI

Шевченко Ю.Л. Качество лабораторного анализа. Приказ Минздрава РФ от 07.02.2000 № 45 «О системе мер по повышению качества клинических лабораторных исследований в учреждениях здравоохранения РФ». Медицинская редакция «Главный врач». Библиотека журнала «Качество медицинской помощи» 2000, № 2. Доступно по: https://docs.cntd.ru/document/901755005

ГОСТ Р ИСО 5725-2002. Доступно по: https://neo-chaos.narod.ru/useful/gost/gost_r_iso_5725-1-2002.pdf

Лукичёва Т.И., Меньшиков В.В., Пименова Л.М. Биологическая вариация: единая мера точности для лабораторной аналитики и диагностики. Москва: Евролинц, 2004. 173 c. EDN: QKNFMX

Horwitz W., Kamps L.R., Boyer K.W. Quality assurance in the analysis of foods and trace constituents // J. Assoc. Off. Anal. Chem. 1980. Vol. 63, N 6. P. 1344–1354. doi: 10.1093/jaoac/63.6.1344

Thompson M. The amazing Horwitz function // AMC Technical Brief. 2004. N 17.

Гусев Н.Г. Справочник по радиоактивным излучениям и защите. Москва: Медгиз, 1956. 127 c.

Зайчик В.Е., Ментешашвили Г.З. Микроэлементный состав злокачественных опухолей прямой кишки // Актуальные вопросы применения радионуклид. методов исследования в онколог. клинике. Фрунзе, 1983. С. 126–129.

Человек. Медико-биологические данные. Международная комиссия по радиологической защите. Публикация № 23. М.: Медицина, 1977. 496 c.

Costello L.C., Franklin R.B. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots // Mol. Cancer. 2006. Vol. 5. P. 17. doi: 10.1186/1476-4598-5-17 EDN: LOZWJX

Azzalini E., Bonin S. Molecular diagnostics of prostate cancer: impact of molecular tests // Asian J. Androl. 2024. Vol. 26, N 6. P. 562–566. doi: 10.4103/aja202411 EDN: JAQARJ

Schröder F.H. PSA screening-a review of recent studies // Eur. J. Cancer. 2009. Vol. 45, Supple 1. P. 402–404. doi: 10.1016/S0959-8049(09)70065-6

Van Poppel H., Roobol M.J., Chapple C.R., et al. Prostate-specific antigen testing as part of a risk-adapted early detection strategy for prostate cancer: European Association of Urology position and recommendations for 2021 // Eur. Urol. 2021. Vol. 80, N 6. P. 703–711. doi: 10.1016/j.eururo.2021.07.024 EDN: NVMORN

Platz E.A., Helzlsouer K.J., Hoffman S.C., et al. Prediagnostic toenail cadmium and zinc and subsequent prostate cancer risk // Prostate. 2002. Vol. 52, N 4. P. 288–296. doi: 10.1002/pros.10115 EDN: LOZVIP

Nejad S.S., Golzari Z., Zangiabadian M., et al. The association between zinc and prostate cancer development: A systematic review and meta-analysis // PLoS One. 2024. Vol. 19, N 3. P. e0299398. doi: 10.1371/journal.pone.0299398 EDN: ATFJJW

Sugimoto R., Lee L., Tanaka Y., et al. Zinc deficiency as a general feature of cancer: a review of the literature // Biol. Trace Elem. Res. 2024. Vol. 202, N 5. P. 1937–1947. doi: 10.1007/s12011-023-03818-6 EDN: NKIZRD

Lim J.T., Tan Y.Q., Valeri L., et al. Association between serum heavy metals and prostate cancer risk - A multiple metal analysis // Environ. Int. 2019. Vol. 132. P. 105109. doi: 10.1016/j.envint.2019.105109 EDN: YEYAYE

Lu Y., Su H., Wang Y., Li H. Micronutrients and risks of three main urologic cancers: A mendelian randomization study // Front. Nutr. 2023. Vol. 10. P. 1016243. doi: 10.3389/fnut.2023.1016243

Gibson R.S., Hess S.Y., Hotz C., Brown K.H. Indicators of zinc status at the population level: A review of the evidence // Br. J. Nutr. 2008. Vol. 99, Suppl. 3. P. S14–S23. doi: 10.1017/S0007114508006818

Fujita K., Nonomura N. Urinary biomarkers of prostate cancer // Int. J. Urol. 2018. Vol. 25, N 9. P. 770–779. doi: 10.1111/iju.13734 EDN: VIRAEP

Eskra J., Rabizadeh D., Pavlovich C.P., et al. Approaches to urinary detection of prostate cancer // Prostate Cancer Prostatic Dis. 2019. Vol. 22, N 3. P. 362–381. doi: 10.1038/s41391-019-0127-4 EDN: XXNMOR

Moore R.E., Rehkämper M., Kreissig K., et al. Determination of major and trace element variability in healthy human urine by ICP-QMS and specific gravity normalisation // RSC Adv. 2018. Vol. 8, N 66. P. 38022-38035. doi: 10.1039/C8RA06794E

Schilling K., Moore R.E.T., Sullivan K.V., et al. Zinc stable isotopes in urine as diagnostic for cancer of secretory organs // Metallomics. 2021. Vol. 13, N 5. P. mfab020. doi: 10.1093/mtomcs/mfab020 EDN: VCRTKQ

Medarova Z., Ghosh S., Vangel M., et al. Risk stratification of prostate cancer patients based on EPS-urine zinc content // Am. J. Cancer Res. 2014. Vol. 4, N 4. P. 385–393.

Zhang X., Hayes D., Smith S.J., et al. New strategy for quantifying biological zinc by a modified zinpyr fluorescence sensor // J. Am. Chem. Soc. 2008. Vol. 130, N 47. P. 15788–15789. doi: 10.1021/ja807156b

Maddalone M.G., Oderda M., Mengozzi G., et al. Urinary Zinc Loss Identifies Prostate Cancer Patients // Cancers (Basel). 2022. Vol. 14, N 21. P. 5316. doi: 10.3390/cancers14215316 EDN: ABRZZC

Amparore D., Cillis S.D.E., Granato S., et al. Urinary PSA-ZINC biomarker outperforms standard of care in early detection of prostate cancer // Minerva Urol. Nephrol. 2024. Vol. 76, N 3. P. 340–350. doi: 10.23736/s2724-6051.24.05783-5 EDN: GMUMUK

Dehghani P., Karthikeyan V., Tajabadi A., et al. Rapid near-patient impedimetric sensing platform for prostate cancer diagnosis // ACS Omega. 2024. Vol. 9, N 12. P. 14580–14591. doi: 10.1021/acsomega.4c00843 EDN: GMYVQN

Teng Y., Ren Z., Zhang Y., et al. Determination of prostate cancer marker Zn2+ with a highly selective surface-enhanced Raman scattering probe on liquid-liquid self-assembled Au nanoarrays // Talanta. 2020. Vol. 209. P. 120569. doi: 10.1016/j.talanta.2019.120569 EDN: ELRPWB

Chan K.M., Gleadle J.M., O’Callaghan M., et al. Prostate cancer detection: a systematic review of urinary biosensors // Prostate Cancer Prostatic Dis. 2022. Vol. 25, N 1. P. 39–46. doi: 10.1038/s41391-021-00480-8 EDN: LORBOB

Weksler M., Simon A., Lenkinski R.E., et al. A novel modality enables new evidence-based individual risk stratification that can potentially lead to decisive management and treatment decisions in prostate cancer // Diagnostics (Basel). 2023. Vol. 13, N 3. P. 424. doi: 10.3390/diagnostics13030424 EDN: SAEIQO

Shilstein S.S., Breskin A., Chechik R., et al. In vivo determination of prostatic zinc: phantom feasibility study // Phys. Med. Biol. 2004. Vol. 49, N 4. P. 485–499. doi: 10.1088/0031-9155/49/4/001 EDN: LOZVRV

Cortesi M., Chechik R., Breskin A., et al. Evaluating the cancer detection and grading potential of prostatic-zinc imaging: A simulation study // Phys. Med. Biol. 2009. Vol. 54, N 3. P. 781–796. doi: 10.1088/0031-9155/54/3/020 EDN: LOZXAV

Eggener S.E., Scardino P.T., Carroll P.R., et al. Focal therapy for localized prostate cancer: A critical appraisal of rational and modalities // J. Urol. 2007. Vol. 178, N 6. P. 2260–2267. doi: 10.1016/j.juro.2007.08.072

Ghosh S.K., Kim P., Zhang X.A., et al. A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing // Cancer Res. 2010. Vol. 70, N 15. P. 6119–6127. doi: 10.1158/0008-5472.CAN-10-1008 EDN: MXXOKR

Hirayama T., Taki M., Akaoka K., Yamamoto Y. Development of a dual functional luminescent sensor for zinc ion based on a peptidic architecture // Bioorg. Med. Chem. Lett. 2012. Vol. 22, N 24. P. 7410–7413. doi: 10.1016/j.bmcl.2012.10.061

Sivaraman G., Anand T., Chellappa D. Turn-on fluorescent chemosensor for Zn(II) via ring opening of rhodamine spirolactam and their live cell imaging // Analyst. 2012. Vol. 137, N 24. P. 5881–5884. doi: 10.1039/c2an36209k

Thirupathi P., Lee K.H. A ratiometric fluorescent detection of Zn(II) in aqueous solutions using pyrene-appended histidine // Bioorg. Med. Chem. Lett. 2013. Vol. 23, N 24. P. 6811–6815. doi: 10.1016/j.bmcl.2013.10.015

Sivaraman G., Anand T., Chellappa D. Pyrene based selective-ratiometric fluorescent sensing of zinc and pyrophosphate ions // Anal. Methods. 2014. Vol. 7, P. 1–6. doi: 10.1039/C3AY42057D

Vidya B., Sivaraman G., Sumesh R.V. Fluorescein-based “turn on” fluorescence detection of Zn2+ and its applications in imaging of Zn2+ in apoptotic cells // ChemistrySelect. 2016. Vol. 1, N 13. P. 4024–4029. doi: 10.1002/slct.201600863

Ganesan J.S., Gandhi S., Radhakrishnan K. Execution of julolidine based derivative as bifunctional chemosensor for Zn(2+) and Cu(2+) ions: Applications in bio-imaging and molecular logic gate // Spectrochim. Acta A. 2019. Vol. 219. P. 33–43. doi: 10.1016/j.saa.2019.04.029

Mariyappan M., Malini N., Sivamani J. Turn-on fluorescence chemosensor for Zn(2+) ion using salicylate based azo derivatives and their application in cell-bioimaging // J. Fluoresc. 2019. Vol. 29, N 3. P. 737–749. doi: 10.1007/s10895-019-02382-4 EDN: SEFQSE

Karmegam M.V., Karuppannan S., Leslee D.B.C., et al. Phenothiazine-rhodamine-based colorimetric and fluorogenic ‘turn-on’ sensor for Zn(2+) and bioimaging studies in live cells // Luminescence. 2020. Vol. 35, N 1. P. 90–97. doi: 10.1002/bio.3701

An Y., Chang W., Wang W., et al. A novel tetrapeptide fluorescence sensor for early diagnosis of prostate cancer based on imaging Zn2+ in healthy versus cancerous cells // J. Adv. Res. 2020. Vol. 24. P. 363–370. doi: 10.1016/j.jare.2020.04.008 EDN: BRIGQD

Fu S., Wan X., Du C., et al. A novel fluorescent probe for the early detection of prostate cancer based on endogenous zinc sensing // Prostate. 2019. Vol. 79, N 12. P. 1378–1385. doi: 10.1002/pros.23844

Yousaf T., Dervenoulas G., Politis M. Advances in MRI Methodology // Int. Rev. Neurobiol. 2018. Vol. 141. P. 31–76. doi: 10.1016/bs.irn.2018.08.008

Manias K.A., Gill S.K., MacPherson L., et al. Magnetic resonance imaging based functional imaging in paediatric oncology // Eur. J. Cancer. 2017. Vol. 72. P. 251–265. doi: 10.1016/j.ejca.2016.10.037 EDN: YXBKMT

Lohrke J., Frenzel T., Endrikat J., et al. 25 Years of Contrast-Enhanced MRI: Developments, Current Challenges and Future Perspectives // Adv. Ther. 2016. Vol. 33. P. 1–28. doi: 10.1007/s12325-015-0275-4 EDN: BDFWHS

Hanaoka K., Kikuchi K., Urano Y., Nagano T. Selective sensing of zinc ions with a novel magnetic resonance imaging contrast agent // J. Chem. Soc. Perkin Trans. 2001. Vol. 9. P. 1840–1843. doi: 10.1039/b100994j EDN: AUFAQN

Khalighinejad P., Parrott D., Sherry A.D. Imaging tissue physiology in vivo by use of metal ion-responsive MRI contrast agents // Pharmaceuticals. 2020. Vol. 13, N 10. P. 268. doi: 10.3390/ph13100268 EDN: TXNXPD

Clavijo Jordan M.V., Lo S.T., Chen S., et al. Zinc-sensitive MRI contrast agent detects differential release of Zn(II) ions from the healthy vs. malignant mouse prostate // Proc. Natl. Acad. Sci. USA. 2016. Vol. 113, N 37. P. E5464–E5471. doi: 10.1073/pnas.1609450113 EDN: XUIGJN

Clavijo Jordan V., Al-Ebraheem A., Geraki K., et al. Synchrotron radiation x-ray fluorescence elemental mapping in healthy versus malignant prostate tissues provides new insights into the glucose-stimulated zinc trafficking in the prostate as discovered by MRI // Inorg. Chem. 2019. Vol. 58, N 20. P. 13654–13660. doi: 10.1021/acs.inorgchem.9b01132 EDN: TTTUFO

Khalighinejad P., Parrott D., Jordan V.C., et al. Magnetic resonance imaging detection of glucose-stimulated zinc secretion in the enlarged dog prostate as a potential method for differentiating prostate cancer from benign prostatic hyperplasia // Invest. Radiol. 2021. Vol. 56, N 7. P. 450–457. doi: 10.1097/RLI.0000000000000760 EDN: WEOAEH

Behzadi A.H., Zhao Y., Farooq Z., Prince M.R. Immediate allergic reactions to gadolinium-based contrast agents: a systematic review and meta-analysis // Radiology. 2018. Vol. 286, N 2. P. 471–482. doi: 10.1148/radiol.2017162740

Costello J.R., Kalb B., Martin D.R. Incidence and risk factors for gadolinium-based contrast agent immediate reactions // Top. Magn. Reson. Imaging. 2016. Vol. 25, N 6. P. 257–263. doi: 10.1097/RMR.0000000000000109

Olchowy C., Cebulski K., Łasecki M., et al. The presence of the gadolinium-based contrast agent depositions in the brain and symptoms of gadolinium neurotoxicity-a systematic review // PLoS One. 2017. Vol. 12, N 2. P. e0171704. doi: 10.1371/journal.pone.0171704

Layne K.A., Dargan P.I., Archer J.R.H., Wood D.M. Gadolinium deposition and the potential for toxicological sequelae-a literature review of issues surrounding gadolinium-based contrast agents // Br. J. Clin. Pharmacol. 2018. Vol. 84, N 11. P. 2522–2534. doi: 10.1111/bcp.13718

Yuan Y., Wei Z., Chu C., et al. Development of zinc-specific iCEST MRI as an imaging biomarker for prostate cancer // Angew. Chem. Int. Ed. Engl. 2019. Vol. 58, N 43. P. 15512–15517. doi: 10.1002/anie.201909429 EDN: WAGSIW

Cineus R., Dissanayake A., Morrow J.R. Zn(II) responsive MRI probe based on an Fe(III) macrocyclic complex // Inorg. Chem. 2024. Vol. 63, N 51. P. 24049–24053. doi: 10.1021/acs.inorgchem.4c04136 EDN: LCGYTX

Hennigar S.R., Kelleher S.L. Zinc networks: the cell-specific compartmentalization of zinc for specialized functions // Biol. Chem. 2012. Vol. 393, N 7. P. 565–578. doi: 10.1515/hsz-2012-0128

Livingstone C. Zinc: Physiology, deficiency, and parenteral nutrition // Nutr. Clin. Pract. 2015. Vol. 30, N 3. P. 371–382. doi: 10.1177/0884533615570376 EDN: UPGGXJ

King J.C., Brown K.H., Gibson R.S., et al. Biomarkers of nutrition for development (BOND)-Zinc review // J. Nutr. 2016. Vol. 146, N 4. P. 858S–885S. doi: 10.3945/jn.115.220079

Chasapis C.T., Ntoupa P.-S.A., Spiliopoulou C.A., Stefanidou M.E. Recent aspects of the effects of zinc on human health // Arch. Toxicol. 2020. Vol. 94, N 5. P. 1443–1460. doi: 10.1007/s00204-020-02702-9 EDN: XDDDWB

Tapiero H., Tew K.D. Trace elements in human physiology and pathology: zinc and metallothioneins // Biomed. Pharmacother. 2003. Vol. 57, N 9. P. 399–411. doi: 10.1016/S0753-3322(03)00081-7 EDN: XRDNAE

Gumulec J., Masarik M., Krizkova S., et al. Insight to physiology and pathology of zinc(II) ions and their actions in breast and prostate carcinoma // Curr. Med. Chem. 2011. Vol. 18, N 33. P. 5041–5051. doi: 10.2174/092986711797636126

Bafaro E., Liu Y., Xu Y., Dempski E. The emerging role of zinc transporters in cellular homeostasis and cancer // Signal Transduct. Target. Ther. 2017. Vol. 2. P. 17029. doi: 10.1038/sigtrans.2017.29 EDN: NRRKAE

Pan Z., Choi S., Ouadid-Ahidouch H., et al. Zinc transporters and dysregulated channels in cancers // Front. Biosci. (Landmark Ed.). 2017. Vol. 22, N 4. P. 623–643. doi: 10.2741/4507 EDN: ISJOGM

Danscher G., Stoltenberg M. Zinc-specific autometallographic in vivo selenium methods: Tracing of zinc-enriched (zen) terminals, zen pathways and pools of zinc ions in a multitude of other zen cells // J. Histochem. Cytochem. 2005. Vol. 53, N 2. P. 141–153. doi: 10.1369/jhc.4R6460.2005

Maret W. Zinc and human disease // Met. Ions Life Sci. 2013. Vol. 13. P. 389–414. doi: 10.1007/978-94-007-7500-8_12

Jackson M.A., Slininger P.J., Bothast R.J. Effects of zinc, iron, cobalt and manganese on fusarium moniliforme nrrl 13616 growth and fusarin c biosynthesis in submerged cultures // Appl. Environ. Microbiol. 1989. Vol. 55, N 3. P. 649–655. doi: 10.1128/aem.55.3.649-655.1989

King J.C., Shames D.M., Woodhouse L.R. Zinc homeostasis in humans // J. Nutr. 2000. Vol. 130, N 5S. P. 1360S–1366S. doi: 10.1093/jn/130.5.1360S

Roohani N., Hurrell R., Kelishadi R., Schulin R. Zinc and its importance for human health: An integrative review // J. Res. Med. Sci. 2013. Vol. 18, N 2. P. 144–157.

Kambe T., Hashimoto A., Fujimoto S. Current understanding of zip and znt zinc transporters in human health and diseases // Cell. Mol. Life Sci. 2014. Vol. 71, N 17. P. 3281–3295. doi: 10.1007/s00018-014-1617-0

Outten C.E., O’Halloran T.V. Femtomolar sensitivity of metalloregulatory proteins controlling zinc homeostasis // Science. 2001. Vol. 292, N 5526. P. 2488–2492. doi: 10.1126/science.1060331 EDN: DMEXCZ

Miller L.V., Hambidge K.M., Naake V.L., et al. Size of the zinc pools that exchange rapidly with plasma zinc in humans: Alternative techniques for measuring and relation to dietary zinc intake // J. Nutr. 1994. Vol. 124, N 2. P. 268–276. doi: 10.1093/jn/124.2.268

Ebisch I.M., Thomas C., Peters W., Braat D., Steegers-Theunissen R.P.M. The importance of folate, zinc and antioxidants in the pathogenesis and prevention of subfertility // Hum. Reprod. Update. 2006. Vol. 13, N 2. P. 163–174. doi: 10.1093/humupd/dml054 EDN: LUIAGJ

Murarka S., Mishra V., Joshi P., Kumar S. Role of zinc in reproductive biology-An overview // Austin J. Reprod. Med. Infertil. 2015. Vol. 2, N 2. P. 1009.

Nasiadek M., Stragierowicz J., Klimczak M., Kilanowicz A. The role of zinc in selected female reproductive system disorders // Nutrients. 2020. Vol. 12, N 8. P. 2464. doi: 10.3390/nu12082464 EDN: RKXRZW

Cousins R.J. Absorption, transport, and hepatic metabolism of copper and zinc: Special reference to metallothionein and ceruloplasmin // Physiol. Rev. 1985. Vol. 65, N 2. P. 238–309. doi: 10.1152/physrev.1985.65.2.238

Krebs N.F. Overview of zinc absorption and excretion in the human gastrointestinal tract // J. Nutr. 2000. Vol. 130, N 5S. P. 1374S–1377S. doi: 10.1093/jn/130.5.1374S

Turnlund J.R., King J.C., Keyes W.R., Gong B., Michel M.C. A stable isotope study of zinc absorption in young men: Effects of phytate and alpha-cellulose // Am. J. Clin. Nutr. 1984. Vol. 40, N 5. P. 1071–1077. doi: 10.1093/ajcn/40.5.1071

Sandström B., Almgren A., Kivistö B., Cederblad A. Effect of protein level and protein source on zinc absorption in humans // J. Nutr. 1989. Vol. 119, N 1. P. 48–53. doi: 10.1093/jn/119.1.48

Lonnerdal B. Dietary factors influencing zinc absorption // J. Nutr. 2000. Vol. 130, N 5S. P. S1378–1383. doi: 10.1093/jn/130.5.1378S

Cousins R.J., McMahon R.J. Integrative aspects of zinc transporters // J. Nutr. 2000. Vol. 130, N 5S Suppl. P. 1384S–1387S. doi: 10.1093/jn/130.5.1384S

Filippini T., Cilloni S., Malavolti M., et al. Dietary intake of cadmium, chromium, copper, manganese, selenium and zinc in a Northern Italy community // J. Trace Elem. Med. Biol. 2018. Vol. 50. P. 508–517. doi: 10.1016/j.jtemb.2018.03.001 EDN: YGBHCH

World Health Organization (WHO), Food and Agricultural Organization (FAO). Vitamin and Mineral Requirements in Human Nutrition. 2nd ed. WHO; Geneva, Switzerland: 2004. 340 p.

Institute of Medicine (IOM). Dietary reference intakes of vitamin a, vitamin k, arsenic boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, WA, USA: National Academy Press, 2002.

European Food Safety Authority. Scientific opinion on dietary reference values of zinc (EFSA) // EFSA Panel on dietetic products, nutrition and allergies (NDA) EFSA J. 2014. Vol. 12, N 10. P. 3844.

Fairweather-Tait S., Hurrell R.F. Bioavailability of minerals and trace elements // Nutr. Res. Rev. 1996. Vol. 9, N 1. P. 295–324. doi: 10.1079/NRR19960016

Johnson P.E., Hunt C.D., Milne D.B., Mullen L.K. Homeostatic control of zinc metabolism in men: Zinc excretion and balance in men fed diets low in zinc // Am. J. Clin. Nutr. 1993. Vol. 57, N 4. P. 557–565. doi: 10.1093/ajcn/57.4.557

Cousins R.J., Liuzzi J.P., Lichten L.A. Mammalian zinc transport, trafficking and signals // J. Biol. Chem. 2006. Vol. 281, N 34. P. 24085–24089. doi: 10.1074/jbc.R600011200

Johnson L.A., Kanak M.A., Kajdacsy-Balla A., Pestaner J.P., Bagasra O. Differential zinc accumulation and expression of human zinc transporter 1 (hZIP1) in prostate glands // Methods. 2010. Vol. 52, N 4. P. 316–321. doi: 10.1016/j.ymeth.2010.08.004 EDN: OKQNKL

Prasad A.S., Miale A. Jr., Farid Z., et al. Zinc metabolism in patients with the syndrome of iron deficiency anemia, hepatosplenomegaly, dwarfism, and hypognadism // J. Lab. Clin. Med. 1963. Vol. 61. P. 537–549.

Vallee B.L., Falchuk K.H. The biochemical basis of zinc physiology // Physiol. Rev. 1993. Vol. 73, N 1. P. 79–118. doi: 10.1152/physrev.1993.73.1.79

Bhowmik D., Bhattacharjee C., Kumar S. A potential medicinal importance of zinc in human health and chronic disease // Int. J. Pharm. Biomed. Sci. 2010. Vol. 1, N 1. P. 5–11.

Sauer A.K., Vela H., Vela G., et al. Zinc deficiency in men over 50 and its implications in prostate disorders // Front. Oncol. 2020. Vol. 10. P. 1293. doi: 10.3389/fonc.2020.01293

Aaron L., Franco O.E., Hayward S.W. Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia // Urol. Clin. North Am. 2016. Vol. 43, N 3. P. 279–288. doi: 10.1016/j.ucl.2016.04.012

Parsons J.K. Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors // Curr. Blad Dysfunc Rep. 2010. Vol. 5, N 4. P. 212–218. doi: 10.1007/s11884-010-0067-2 EDN: YOFYQI

Bergengren O., Pekala K.R., Matsoukas K., et al. 2022 Update on Prostate Cancer Epidemiology and Risk Factors — A Systematic Review // Eur. Urol. 2023. Vol. 84, N 2. P. 191–206. doi: 10.1016/j.eururo.2023.04.021 EDN: IVMJCV

Alcaraz A., Hammerer P., Tubaro A., et al. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review // Eur. Urol. 2009. Vol. 55, N 4. P. 864–873. doi: 10.1016/j.eururo.2008.11.011

Hambidge K.M., Casey C.E., Krebs N.F. Zinc // Trace elements in human and animal nutrition. 5th ed. Vol 2. New York: Academic Press, 1986. P. 1–137.

Gagliardi L.J., Shain D.H. Biophysical mechanism for zinc as an anticancer agent // Med. Hypotheses. 2020. Vol. 144. P. 110273. doi: 10.1016/j.mehy.2020. 110273 EDN: ALHXAU

Schrauzer G.N., White D.A., Schneider C.J. Cancer mortality correlation studies. IV. Associations with dietary intakes and blood levels of certain trace elements, notably Se-antagonists // Bioinorg. Chem. 1977. Vol. 7, N 1. P. 35–56. doi: 10.1016/S0006-3061(00)80127-1

Costello L.C., Liu Y., Franklin R.B., Kennedy M.C. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells // J. Biol. Chem. 1997. Vol. 272, N 46. P. 28875–28881. doi: 10.1074/jbc.272.46.28875

Gray M.A., Centeno J.A., Slaney D.P., et al. Environmental exposure to trace elements and prostate cancer in three New Zealand ethnic groups // Int. J. Environ. Res. Public Health. 2005. Vol. 2, N 3–4. P. 374–384. doi: 10.3390/ijerph2005030001

Schuman L.M., Mandel J.S. Epidemiology of prostatic cancer in blacks // Prev. Med. 1980. Vol. 9, N 5. P. 630–649. doi: 10.1016/0091-7435(80)90035-3

Weisburger J.H., Reddy B.S., Hill P., et al. Nutrition and cancer-on the mechanisms bearing on causes of cancer of the colon, breast, prostate, and stomach // Bull. N.Y. Acad. Med. 1980. Vol. 56, N 8. P. 673–696.

Mettlin C. Nutritional habits of blacks and whites // Prev. Med. 1980. Vol. 9, N 5. P. 601–606. doi: 10.1016/0091-7435(80)90031-6

Snowdon D.A., Phillips R.L., Choi W. Diet, obesity, and risk of fatal prostate cancer // Am. J. Epidemiol. 1984. Vol. 120, N 2. P. 244–250. doi: 10.1093/oxfordjournals.aje.a113886 EDN: HONUFR

Talamini R., La Vecchia C., Decarli A., et al. Nutrition, social factors and prostatic cancer in a Northern Italian population // Br. J. Cancer. 1986. Vol. 53, N 6. P. 817–821. doi: 10.1038/bjc.1986.138

Boyle P., Zaridze D.G. Risk factors for prostate and testicular cancer // Eur. J. Cancer. 1993. Vol. 29A, N 7. P. 1048–1055. doi: 10.1016/S0959-8049(05)80222-9 EDN: XNYLIV

Chan J.M., Giovannucci E.L. Dairy products, calcium, and vitamin D and risk of prostate cancer // Epidemiol. Rev. 2001. Vol. 23, N 1. P. 87–92. doi: 10.1093/oxfordjournals.epirev.a000800

Michaud D.S., Augustsson K., Rimm E.B., et al. A prospective study on intake of animal products and risk of prostate cancer // Cancer Causes Control. 2001. Vol. 12, N 6. P. 557–567. doi: 10.1023/A:1011256201044 EDN: AROETF

Chan J.M., Stampfer M.J., Ma J., et al. Dairy products, calcium, and prostate cancer risk in the Physicians’ Health Study // Am. J. Clin. Nutr. 2001. Vol. 74, N 4. P. 549–554. doi: 10.1093/ajcn/74.4.549

Chan J.M., Gann P.H., Giovannucci E.L. Role of diet in prostate cancer development and progression // J. Clin. Oncol. 2005. Vol. 23, N 32. P. 8152–8160. doi: 10.1200/JCO.2005.03.1492

Cross A.J., Peters U., Kirsh V.A., et al. A prospective study of meat and meat mutagens and prostate cancer risk // Cancer Res. 2005. Vol. 65, N 24. P. 11779–11784. doi: 10.1158/0008-5472.CAN-05-2191

Walker M., Aronson K.J., King W., et al. Dietary patterns and risk of prostate cancer in Ontario, Canada // Int. J. Cancer. 2005. Vol. 116, N 4. P. 592–598. doi: 10.1002/ijc.21112

Giovannucci E., Liu Y., Stampfer M.J., Willett W.C. A prospective study of calcium intake and incident and fatal prostate cancer // Cancer Epidemiol. Biomarkers Prev. 2006. Vol. 15, N 2. P. 203–210. doi: 10.1158/1055-9965.EPI-05-0586

Giovannucci E., Liu Y., Platz E.A., et al. Risk factors for prostate cancer incidence and progression in the health professionals follow-up study // Int. J. Cancer. 2007. Vol. 121, N 7. P. 1571–1578. doi: 10.1002/ijc.22788

Mitrou P.N., Albanes D., Weinstein S.J., et al. A prospective study of dietary calcium, dairy products and prostate cancer risk (Finland) // Int. J. Cancer. 2007. Vol. 120, N 11. P. 2466–2473. doi: 10.1002/ijc.22553

Park Y., Mitrou P.N., Kipnis V., et al. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study // Am. J. Epidemiol. 2007. Vol. 166, N 11. P. 1270–1279. doi: 10.1093/aje/kwm268 EDN: IKOESP

Stacewicz-Sapuntzakis M., Bowen P.E., Borthakur G., Burns J.L. Correlations of dietary patterns with prostate health // Mol. Nutr. Food Res. 2008. Vol. 52, N 1. P. 114–130. doi: 10.1002/mnfr.200600296 EDN: LOZWTD

Butler L.M., Wong A.S., Koh W.P., et al. Calcium intake increases risk of prostate cancer among Singapore Chinese // Cancer Res. 2010. Vol. 70, N 12. P. 4941–4948. doi: 10.1158/0008-5472.CAN-09-4544

Kristal A.R., Arnold K.B., Neuhouser M.L., et al. Diet, supplement use, and prostate cancer risk: results from the prostate cancer prevention trial // Am. J. Epidemiol. 2010. Vol. 172, N 5. P. 566–577. doi: 10.1093/aje/kwq148

Raimondi S., Mabrouk J.B., Shatenstein B., et al. Diet and prostate cancer risk with specific focus on dairy products and dietary calcium: a case-control study // Prostate. 2010. Vol. 70, N 10. P. 1054–1065. doi: 10.1002/pros.21139

Rowland G.W., Schwartz G.G., John E.M., Ingles S.A. Calcium intake and prostate cancer among African Americans: effect modification by vitamin D receptor calcium absorption genotype // J. Bone Miner. Res. 2012. Vol. 27, N 1. P. 187–194. doi: 10.1002/jbmr.505

Rowland G.W., Schwartz G.G., John E.M., Ingles S.A. Protective effects of low calcium intake and low calcium absorption vitamin D receptor genotype in the California Collaborative Prostate Cancer Study // Cancer Epidemiol. Biomarkers Prev. 2013. Vol. 22, N 1. P. 16–24. doi: 10.1158/1055-9965.EPI-12-0922-T

Aslam R., Neubauer S. Dairy foods, milk, calcium, and risk of prostate cancer // Oncol. Nutr. Connect. 2013. Vol. 21, N 1. P. 3–10.

Song Y., Chavarro J.E., Cao Y., et al. Whole milk intake is associated with prostate cancer-specific mortality among U.S. male physicians // J. Nutr. 2013. Vol. 143, N 2. P. 189–196. doi: 10.3945/jn.112.168484

Lin P.H., Aronson W., Freedland S.J. Nutrition, dietary interventions and prostate cancer: the latest evidence // BMC Med. 2015. Vol. 13. P. 3. doi: 10.1186/s12916-014-0234-y EDN: NQHXCA

Batai K., Murphy A.B., Ruden M., et al. Race and BMI modify associations of calcium and vitamin D intake with prostate cancer // BMC Cancer. 2017. Vol. 17, N 1. 64. doi: 10.1186/s12885-017-3060-8 EDN: IJUCOC

Schmid H.P., Fischer C., Engeler D.S., et al. Nutritional aspects of primary prostate cancer prevention // Recent Results Cancer Res. 2011. Vol. 188. P. 101–107. doi: 10.1007/978-3-642-10858-7_8 EDN: OAKIVL

Mandair D., Rossi R.E., Pericleous M., et al. Prostate cancer and the influence of dietary factors and supplements: a systematic review // Nutr. Metab. (Lond). 2014. Vol. 11. P. 30. doi: 10.1186/1743-7075-11-30 EDN: CRCBXZ

Ballon-Landa E., Parsons J.K. Nutrition, physical activity, and lifestyle factors in prostate cancer prevention // Curr. Opin. Urol. 2018. Vol. 28, N 1. P. 55–61. doi: 10.1097/MOU.0000000000000460

Oczkowski M., Dziendzikowska K., Pasternak-Winiarska A., et al. Dietary factors and prostate cancer development, progression, and reduction // Nutrients. 2021. Vol. 13, N 2. P. 496. doi: 10.3390/nu13020496 EDN: KEVDSA

Cirne F., Kappel C., Zhou S., et al. Modifiable risk factors for prostate cancer in low- and lower-middle-income countries: a systematic review and meta-analysis // Prostate Cancer Prostatic Dis. 2022. Vol. 25, N 3. P. 453–462. doi: 10.1038/s41391-022-00570-1 EDN: WWIYGT

Al-Ghazawi M., Salameh H., Amo-Afful S., et al. An in-depth look into the epidemiological and etiological aspects of prostate cancer: A literature review // Cureus. 2023. Vol. 15, N 11. P. e48252. doi: 10.7759/cureus.48252 EDN: TSRGDZ

Galván G.C., Daniels J.P., Friedrich N.A., et al. A healthy diet, a healthy prostate? A brief commentary on the latest research on diet and prostate cancer // Prostate Cancer Prostatic Dis. 2023. Vol. 26, N 4. P. 641–642. doi: 10.1038/s41391-023-00651-9 EDN: EKQLJS

Cui H., Zhang W., Zhang L., et al. Risk factors for prostate cancer: An umbrella review of prospective observational studies and mendelian randomization analyses // PLoS Med. 2024. Vol. 21, N 3. P. e1004362. doi: 10.1371/journal.pmed.1004362 EDN: NFNJGV

Kolonel L.N., Yoshizawa C.N., Hankin J.H. Diet and prostatic cancer: a case-control study in Hawaii // Am. J. Epidemiol. 1988. Vol. 127, N 5. P. 999–1012. doi: 10.1093/oxfordjournals.aje.a114903 EDN: IKKCDB

West D.W., Slattery M.L., Robison L.M., et al. Adult dietary intake and prostate cancer risk in Utah: a case-control study with special emphasis on aggressive tumors // Cancer Causes Control. 1991. Vol. 2, N 2. P. 85–94. doi: 10.1007/bf00053126 EDN: LZEOZZ

Parr R.M., Crawley H., Abdulla M., et al. Human dietary intakes of trace elements. A global literature survey mainly for the period 1970–1991: 1. Data listings and sources of information. Vienna: International Atomic Energy Agency, 1992. 111 p. Available from: https://inis.iaea.org/records/heqb2-29k16

Fitzpatrick J.N., Kranе R.J. (еds). Thе prostate. Edinburgh, London, Melbourne and New York: Churchill Livingstone, 1989. 449 p.

Gutiérrez-González E., Castelló A., Fernández-Navarro P., et al. Dietary zinc and risk of prostate cancer in Spain: MCC-Spain study // Nutrients. 2019. Vol. 11, N 1. P. 18. doi: 10.3390/nu11010018

Sebastian R.S., Cleveland L.E., Goldman J.D., et al. Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes // J. Am. Diet. Assoc. 2007. Vol. 107, N 8. P. 1322–1332. doi: 10.1016/j.jada.2007.05.010

Kantor E.D., Rehm C.D., Du M., et al. Trends in dietary supplement use among US adults from 1999–2012 // JAMA. 2016. Vol. 316, N 14. P. 1464–1474. doi: 10.1001/jama.2016.14403

Li J., Li X., Gathirua-Mwangi W., et al. Prevalence and trends in dietary supplement use among US adults with diabetes: the National Health and Nutrition Examination Surveys, 1999–2014 // BMJ Open Diabetes Res. Care. 2020. Vol. 8, N 1. P. e000925. doi: 10.1136/bmjdrc-2019-000925 EDN: SSNJBO

Leitzmann M.F., Stampfer M.J., Wu K., et al. Zinc supplement use and risk of prostate cancer // J. Natl. Cancer Inst. 2003. Vol. 95, N 13. P. 1004–1007. doi: 10.1093/jnci/95.13.1004 EDN: LOZVMV

Zhang Y., Coogan P., Palmer J.R., et al. Vitamin and mineral use and risk of prostate cancer: the case-control surveillance study // Cancer Causes Control. 2009. Vol. 20, N 5. P. 691–698. doi: 10.1007/s10552-008-9282-y EDN: GNSWYI

Zhang Y., Song M., Mucci L.A., et al. Zinc supplement use and risk of aggressive prostate cancer: a 30-year follow-up study // Eur. J. Epidemiol. 2022. Vol. 37, N 12. P. 1251–1260. doi: 10.1007/s10654-022-00922-0 EDN: IHVMMS

Jabbari P., Yazdanpanah O., Benjamin DJ., et al. Supplement use and increased risks of cancer: Unveiling the other side of the coin // Cancers (Basel). 2024. Vol. 16, N 5. P. 880. doi: 10.3390/cancers16050880 EDN: YMIBLT

Ko Y.H., Woo Y.J., Kim J.W., et al. High-dose dietary zinc promotes prostate intraepithelial neoplasia in a murine tumor induction model // Asian J. Androl. 2010. Vol. 12, N 2. P. 164–170. doi: 10.1038/aja.2009.74 EDN: MKMRWV

Prasad A.S., Mukhtar H., Beck F.W., et al. Dietary zinc and prostate cancer in the TRAMP mouse model // J. Med. Food. 2010. Vol. 13, N 1. P. 70–76. doi: 10.1089/jmf.2009.0042 EDN: YVLBGL

Li X.M., Zhang L., Li J., et al. Measurement of serum zinc improves prostate cancer detection efficiency in patients with PSA levels between 4 ng/mL and 10 ng/mL // Asian J. Androl. 2005. Vol. 7, N 3. P. 323–328. doi: 10.1111/j.1745-7262.2005.00044.x EDN: LOZWAR

Aydin A., Arsova-Sarafinovska Z., Sayal A., et al. Oxidative stress and antioxidant status in non-metastatic prostate cancer and benign prostatic hyperplasia // Clin. Biochem. 2006. Vol. 39, N 2. P. 176–179. doi: 10.1016/j.clinbiochem. 2005.11.018

Kaba M., Pirincci N., Yuksel M.B., et al. Serum levels of trace elements in patients with prostate cancer // Asian Pac. J. Cancer Prev. 2014. Vol. 15, N 6. P. 2625–2629. doi: 10.7314/APJCP.2014.15.6.2625

Chen G., Wu L., Wu Y., Zhu J. Content change of zinc and cadmium in serum of patients with prostate cancer and its clinical significance // J. Clin. Urol. 2015. Vol. 30. P. 439–441.

Onyema-iloh B.O., Meludu S.C., Iloh E., et al. Biochemical changes in some trace elements, antioxidant vitamins and their therapeutic importance in prostate cancer patients // Asian J. Med. Sci. 2015. Vol. 6, N 1. P. 95–97. doi: 10.3126/ajms.v6i1.10799

Wakwe V.C., Odum E.P., Amadi C. The impact of plasma zinc status on the severity of prostate cancer disease // Investig. Clin. Urol. 2019. Vol. 60, N 3. P. 162–168. doi: 10.4111/icu.2019.60.3.162 EDN: YSYCQV

Yao D., Johnes A., Fragmann C. The content of serum zinc concentration in prostate disease // Int. J. Surg. 1977. Vol. 4. P. 225–227.

Habib F.K., Dembinski T.C., Stitch S.R. The zinc and copper content of blood leucocytes and plasma from patients with benign and malignant prostates // Clin. Chem. Acta. 1980. Vol. 104, N 3. P. 329–335. doi: 10.1016/0009-8981(80)90390-3

Feustel A., Wennrich R., Schmidt B. Serum-Zn-levels in prostatic cancer // Urol. Res. 1989. Vol. 17, N 1. P. 41–42. doi: 10.1007/bf00261049 EDN: VVNPRB

Adedapo K.S., Arinola O.G., Shittu O.B., et al. Diagnostic value of lipids, total antioxidants, and trace metals in benign prostate hyperplasia and prostate cancer // Niger. J. Clin. Pract. 2012. Vol. 15, N 3. P. 293–297. doi: 10.4103/1119-3077.100623

Rahman M.T., Mumu M.A., Kabir Y., et al. Serum zinc level and prostatic lesion // Mymensingh Med. J. 2012. Vol. 21, N 4. P. 679–683.

Eken A., Ünlü-Endirlik B., Kaya E., et al. Evaluation of trace element levels in patients with prostate cancer, benign prostatic hyperplasia and chronic prostatitis // Gülhane Tıp Derg. 2016. Vol. 58, N 1. P. 27–32. doi: 10.5455/gulhane.193330

Białkowska K., Marciniak W., Muszyńska M., et al. Association of zinc level and polymorphism in MMP-7 gene with prostate cancer in Polish population // PLoS One. 2018. Vol. 13, N 7. P. e0201065. doi: 10.1371/journal.pone.0201065 EDN: YKPKOD

Farahani H., Alaee M., Amri J., et al. Serum and saliva concentrations of biochemical parameters in men with prostate cancer and benign prostate hyperplasia // Lab. Med. 2020. Vol. 51, N 3. P. 243–251. doi: 10.1093/labmed/lmz053

Beyersmann D., Haase H. Functions of zinc in signaling, proliferation and differentiation of mammalian cells // BioMetals. 2001. Vol. 4, N 3–4. P. 331–341. doi: 10.1023/A:1012905406548 EDN: MABTCF

Yu M., Lee WW, Tomar D., et al. Regulation of T cell receptor signaling by activation-induced zinc influx // J. Exp. Med. 2011. Vol. 208, N 4. P. 775–785. doi: 10.1084/jem.20100031

Hojyo S., Miyai T., Fujishiro H., et al. Zinc transporter SLC39A10/ZIP10 controls humoral immunity by modulating B-cell receptor signal strength // Proc. Natl. Acad. Sci. USA. 2014. Vol. 111, N 32. P. 11786–11791. doi: 10.1073/pnas.1323557111

Miyai T., Hojyo S., Ikawa T., et al. Zinc transporter SLC39A10/ZIP10 facilitates antiapoptotic signaling during early B-cell development // Proc. Natl. Acad. Sci. USA. 2014. Vol. 111, N 32. P. 11780–11785. doi: 10.1073/pnas.1323549111

Rosenkranz E., Hilgers RD, Uciechowski P., et al. Zinc enhances the number of regulatory T cells in allergen-stimulated cells from atopic subjects // Eur. J. Nutr. 2017. Vol. 56. P. 557–567. doi: 10.1007/s00394-015-1100-1 EDN: JVFXVL

Anzilotti C., Swan DJ, Boisson B., et al. An essential role for the Zn2+ transporter ZIP7 in B cell development // Nat. Immunol. 2019. Vol. 20, N 3. P. 350–361. doi: 10.1038/s41590-018-0295-8

Moyad M.A. Zinc for prostate disease and other conditions: a little evidence, a lot of hype, and a significant potential problem // Urol. Nurs. 2004. Vol. 24, N 1. P. 49–52.

Hartoma R. Serum testosterone compared with serum zinc in man // Acta Physiol. Scand. 1977. Vol. 101, N 3. P. 336–342. doi: 10.1111/j.1748-1716.1977.tb06015.x

Patel A.R., Klein E.A. Risk factors for prostate cancer // Nat. Clin. Pract. Urol. 2009. Vol. 6, N 2. P. 87–95. doi: 10.1038/ncpuro1290

Wong P.F., Abubakar S. Comparative transcriptional study of the effects of high intracellular zinc on prostate carcinoma cells // Oncol. Rep. 2010. Vol. 23, N 6. P. 1501–1516. doi: 10.3892/or-00000789 EDN: MXYNRP

Sztalmachova M., Hlavna M., Gumulec J., et al. Effect of zinc (II) ions on the expression of pro- and anti-apoptotic factors in high-grade prostate carcinoma cells // Oncol. Rep. 2012. Vol. 28, N 3. P. 806–814. doi: 10.3892/or.2012.1897 EDN: RRHMOR

Chan J.M., Stampfer M.J., Giovannucci E., et al. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study // Science. 1998. Vol. 279, N 5350. P. 563–566. doi: 10.1126/science.279.5350.563 EDN: CTDVLD

Jones H.E., Goddard L., Gee J.M.W., et al. Insulin-like growth factor-I receptor signalling and acquired resistance to gefitinib (ZD1839; Iressa) in human breast and prostate cancer cells // Endocr. Relat. Cancer. 2004. Vol. 11, N 4. P. 793–814. doi: 10.1677/erc.1.00799

Vella V., Malaguarnera R., Lappano R., et al. Recent views of heavy metals as possible risk factors and potential preventive and therapeutic agents in prostate cancer // Mol. Cell. Endocrinol. 2017. Vol. 457. P. 57–72. doi: 10.1016/j.mce.2016.10.020

Cord M.C., Aizenman E. The role of intracellular zinc release in aging, oxidative stress, and Alzheimer’s disease // Front. Aging Neurosci. 2014. Vol. 6. P. 77. doi: 10.3389/fnagi.2014.00077

Tahminur R., Choudhury M. Zinc and benign prostatic hyperplasia (BPH) and prostate cancer (PCa) association // Med. Res. Arch. 2016. Vol. 4, N 7. P. 1–16. doi: 10.18103/mra.v4i7.747

Barnard N.D. Trends in food availability, 1909–2007 // Am. J. Clin. Nutr. 2010. Vol. 91, Suppl. 5. P. 1530S–1536S. doi: 10.3945/ajcn.2010.28701G

National Institutes of Health Office of Dietary Supplements. Zinc, Fact Sheet for Health Professionals 2022. Available from: https://ods.od.nih.gov/factsheets/Zinc-HealthProfessional.

Djinovic-Stojanovic J.M., Nikolic D.M., Vranic D.V., et al. Zinc and magnesium in different types of meat and meat products from the Serbian market // J. Food Compos. Anal. 2017. Vol. 59, N 3. P. 50–54. doi: 10.1016/j.jfca.2017.02.009

Watling C.Z., Schmidt J.A., Dunneram Y., et al. Risk of cancer in regular and low meat-eaters, fish-eaters, and vegetarians: a prospective analysis of UK Biobank participants // BMC Med. 2022. Vol. 20, N 1. P. 73. doi: 10.1186/s12916-022-02256-w EDN: VXTLYS

Parra-Soto S., Ahumada D., Petermann-Rocha F., et al. Association of meat, vegetarian, pescatarian and fish-poultry diets with risk of 19 cancer sites and all cancer: findings from the UK Biobank prospective cohort study and meta-analysis // BMC Med. 2022. Vol. 20, N 1. P. 79. doi: 10.1186/s12916-022-02257-9 EDN: ORPRGG

Costello L.C., Franklin R.B., Feng P., et al. Zinc and prostate cancer: a critical scientific, medical, and public interest issue (United States) // Cancer Causes Control. 2005. Vol. 16, N 8. P. 901–915. doi: 10.1007/s10552-005-2367-y EDN: LOZVZD

Posadzki P., Lee M.S., Onakpoya I., et al. Dietary supplements and prostate cancer: a systematic review of double-blind, placebo-controlled randomised clinical trials // Maturitas. 2013. Vol. 75, N 2. P. 125–130. doi: 10.1016/j.maturitas.2013.03.006

Bortz W.M., Wallace D.H., Wiley D. Sexual function in 1,202 aging males: differentiating aspects // J. Gerontol. Med. Sci. 1999. Vol. 54, N 5. P. M237–M241. doi: 10.1093/gerona/54.5.M237

Korenman S.G. Epidemiology of erectile dysfunction // Endocrine. 2004. Vol. 23, N 2–3. P. 87–91. doi: 10.1385/ENDO:23:2-3:087 EDN: CLNISK

Braun M., Wassmer G., Klotz T., et al. Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’ // Int. J. Impot. Res. 2000. Vol. 12, N 6. P. 305–311. doi: 10.1038/sj.ijir.3900622

Nehra A., Kulaksizoglu H. Global perspectives and controversies in the epidemiology of male erectile dysfunction // Curr. Opin. Urol. 2002. Vol. 12, N 6. P. 493–496. doi: 10.1097/00042307-200211000-00009

Yafi F.A., Jenkins L., Albersen M., et al. Erectile dysfunction // Nat. Rev. Dis. Primers. 2016. Vol. 2. P. 16003. doi: 10.1038/nrdp.2016.3

Karunakaran A., Prabhakaran A., Karunakaran V., et al. Erectile Dysfunction in Alcohol Use Disorder and the change in erectile function after one month of abstinence // J. Addict. Dis. 2024. Vol. 42, N 2. P. 112–121. doi: 10.1080/10550887.2022.2157199

Kaltsas A., Zikopoulos A., Dimitriadis F., et al. Oxidative stress and erectile dysfunction: pathophysiology, impacts, and potential treatments // Curr. Issues Mol. Biol. 2024. Vol. 46, N 8. P. 8807–8834. doi: 10.3390/cimb46080521 EDN: VPCZHH

Leitzmann M.F., Platz E.A., Stampfer M.J., et al. Ejaculation Frequency and Subsequent Risk of Prostate Cancer // JAMA. 2004. Vol. 291, N 13. P. 1578–1586. doi: 10.1001/jama.291.13.1578

Lozano-Lorca M., Olmedo-Requena R., Barrios-Rodríguez R., et al. Ejaculation frequency and prostate cancer: CAPLIFE study // World J. Mens Health. 2023. Vol. 41, N 3. P. 724–733. doi: 10.5534/wjmh.220216 EDN: QUOAQP

Jian Z., Ye D., Chen Y., et al. Sexual activity and risk of prostate cancer: A dose-response meta-analysis // J. Sex. Med. 2018. Vol. 15, N 9. P. 1300–1309. doi: 10.1016/j.jsxm.2018.07.004

Crocetto F., Arcaniolo D., Napolitano L., et al. Impact of sexual activity on the risk of male genital tumors: A systematic review of the literature // Int. J. Environ. Res. Public Health. 2021. Vol. 18, N 16. P. 8500. doi: 10.3390/ijerph18168500 EDN: PKNJTQ

Kokori E., Olatunji G., Isarinade DT., et al. Ejaculation frequency and prostate cancer risk: A narrative review of current evidence // Clin. Genitourin. Cancer. 2024. Vol. 22, N 3. P. 102043. doi: 10.1016/j.clgc.2024.01.015 EDN: ATFQUN

Dimitropoulou P., Lophatananon A., Easton D., et al. Sexual activity and prostate cancer risk in men diagnosed at a younger age // BJU Int. 2009. Vol. 103, N 2. P. 178–185. doi: 10.1111/j.1464-410X.2008.08030.x

Singh C.K., Chhabra G., Patel A., et al. Dietary phytochemicals in zinc homeostasis: a strategy for prostate cancer management // Nutrients. 2021. Vol. 13, N 6. P. 1867. doi: 10.3390/nu13061867 EDN: NQUWKD

Liu V., Van Blarigan E.L, Zhang L., et al. Plant-based diets and disease progression in men with prostate cancer // JAMA Netw. Open. 2024. Vol. 7, N 5. P. e249053. doi: 10.1001/jamanetworkopen.2024.9053 EDN: PGVLUC

Metri N.A., Mandl A., Paller C.J. Harnessing nature’s therapeutic potential: A review of natural products in prostate cancer management // Urol. Oncol. Semin. Orig. Investig. 2025. Vol. 43, N 4. P. 221–243. doi: 10.1016/j.urolonc.2024.12.260

Rooney C., Beral V., Maconochie N., et al. Case control study of prostatic cancer in employees of the United Kingdom Atomic Energy Authority // BMJ. 1993. Vol. 307, N 6916. P. 1391–1397. doi: 10.1136/bmj.307.6916.1391 EDN: BQJQLB

Daniel O., Hadda F., Prout G., Whitmore W.F. Some observation on the distribution of radioactive zinc in prostatic and other human tissues // Br. J. Urol. 1956. Vol. 28, N 3. P. 271–278. doi: 10.1111/j.1464-410X.1956.tb04770.x

Prout G.R.Jr, Sierp M., Whitmore W.F. Radioactive zinc in the prostate. Some factors influencing concentrations in dogs and men // JAMA. 1959. Vol. 169, N 15. P. 1703–1710. doi: 10.1001/jama.1959.03000320005002

Gold F.M., Lorber S.A. Radioisotope -Zn chloride prostate gland scan. I. 69mZn organ distribution studies and gamma-camera scan in canine subjects // Invest. Urol. 1970. Vol. 8, N 2. P. 231–238.

Denmeade S.R., Isaacs J.T. A history of prostate cancer treatment // Nat. Rev. Cancer. 2002. Vol. 2, N 5. P. 389–396. doi: 10.1038/nrc801

James N.D., Tannock I., N’Dow J., et al. The Lancet Commission on prostate cancer: planning for the surge in cases // Lancet. 2024. Vol. 403, N 10437. P. 1683–1722. doi: 10.1016/s0140-6736(24)00651-2 EDN: VOVTOM

Naji W.A., Albyati S.A., Naeemah Y.S. Prostate cancer key risk factors and prevention strategies // Cent. Asian J. Theor. Appl. Sci. 2024. Vol. 5, N 3. P. 113–117.

Li D. Advances of zinc signaling studies in prostate cancer // Int. J. Mol. Sci. 2020. Vol. 21, N 2. P. 667. doi: 10.3390/ijms21020667 EDN: ODWUYU